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Résumé 
Malgré un intérêt grandissant pour la question du devenir des survivants de tumeur cérébrale 
pédiatrique, l’évaluation de leur équilibre est souvent négligée. Les objectifs de nos travaux étaient de 
1) examiner les écrits portant sur l’équilibre chez les survivants de tumeur cérébrale pédiatrique; 2) 
comparer l'équilibre debout et la qualité de vie entre les survivants et un groupe d’enfants témoins; et 
3) examiner l'association entre l'équilibre debout et qualité de vie chez les survivants. 
Notre recension des écrits démontra que les survivants de tumeur cérébrale présentent des 
troubles de l’équilibre, mais les limites méthodologiques des études nous empêchent de conclure de 
manière définitive. Ensuite, nous avons recruté un groupe d’enfants survivants d’une tumeur cérébrale 
de la fosse postérieure et un groupe d’enfants sains. Leur équilibre était évalué à l’aide du Bruininks-
Oseretsky Test of Motor Proficiency-2nd edition (BOT-2) et du Pediatric Balance Scale (PBS). 
Certains participants ont aussi été évalués avec une plate-forme de force où les limites de stabilité 
étaient documentées. Finalement, tous les enfants et leurs parents remplissaient le Pediatric Quality of 
Life Inventory (PedsQL4.0). 
Nos résultats démontrent que les survivants présentent une diminution de l’équilibre mise en 
évidence par le BOT-2, mais que leur qualité de vie est similaire aux enfants sains. La performance au 
BOT-2 est associée à la dimension physique du PedsQL4.0, suggérant une relation entre l’équilibre et 
la qualité de vie.  Nos résultats suggèrent qu’une évaluation de l’équilibre pourrait être bénéfique chez 
cette clientèle afin de mieux cerner ses besoins de réadaptation. 
 
Mots clés: Tumeur cérébrale, pédiatrie, équilibre, qualité de vie, survivant 
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Abstract 
 There is growing interest in studying outcomes in survivors of pediatric brain tumours. 
Physical outcomes, especially balance abilities, are less investigated. Objectives of this thesis are to: 1) 
examine the literature for balance outcomes in survivors of pediatric brain tumours, 2) compare 
standing balance and health-related quality of life (HRQOL) between survivors of pediatric posterior 
fossa brain tumours (PFBT) and typically-developing controls and 3) explore the association between 
balance and HRQOL. 
 A comprehensive review demonstrated that although the literature suggests that survivors of 
pediatric brain tumours display ongoing balance deficits, studies have limitations, emphasizing the 
need for further research.  
Survivors of pediatric PFBT and typically-developing children were recruited and their 
balance assessed with the Bruininks-Oseretsky Test of Motor Proficiency-2nd edition (BOT-2) and 
Pediatric Balance Scale (PBS). Dynamic balance was also evaluated for some participants using a 
force platform. The Pediatric Quality of Life Inventory measured HRQOL. Statistical analyses 
included Mann-Whitney U tests to compare results between groups and Spearman's rank correlation 
coefficient to determine the association between balance and HRQOL. 
 Balance abilities were significantly worse in survivors as measured by the BOT-2. The PBS 
displayed a ceiling effect. Certain laboratory outcome measures suggested balance difficulties. All 
participants’ HRQOL scores were within normative values. In survivors, an association was found 
between BOT-2 scores and the physical dimension of HRQOL. 
 Survivors of PFBT demonstrate persistent balance difficulties, best assessed by the BOT-2; 
however, they report normal HRQOL. Future research should be collaborative and focus upon the best 
ways to manage balance deficits. 
 
Keywords: Brain tumour, pediatrics, balance, health-related quality of life, survivor 
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Chapter 1: Introduction 
With recent progress made in the treatment of pediatric brain tumours, children and 
adolescents are surviving longer than before, with 5-year survival rates reaching 71%.
1
 Consequently, 
there has been increasing interest in studying the long-term outcomes of this growing population of 
survivors to better understand secondary impairments and associated disabilities as well as to establish 
how best to serve this population from a rehabilitation perspective. To date, many different areas have 
been explored such as cognitive, medical, social and educational outcomes.
2-5
 On the other hand, 
physical outcomes have been less frequently investigated in survivors of pediatric brain tumours. 
The most frequent location of pediatric brain tumours is the posterior fossa, a region of the 
brain that includes the cerebellum and brainstem.
6,7
 The cerebellum is known to play a crucial role in 
the control of balance.
8,9
 Other areas, including the basal ganglia, brainstem, thalamus and neocortex, 
and their inter-connections may also influence postural control.
8
 One can expect that a brain tumour, 
especially one located within the posterior fossa, could have deleterious consequences on postural and 
motor control. Therefore, it is surprising that there is not more research conducted into the physical 
outcomes, including balance, of survivors of pediatric brain tumours. 
From a clinical standpoint, physiotherapists working with this population may observe that 
they demonstrate difficulties in maintaining standing balance but there has been a lack of studies 
interested in balance abilities in this population. Furthermore, although there may be a growing need 
for ongoing physiotherapy follow-up in survivors of pediatric brain tumours, it is not always available 
or provided due to a lack of evidence emphasizing the need for continued rehabilitation services. 
Another difficulty physiotherapists face is not having any information regarding how well the available 
clinical assessment tools actually measure standing balance in survivors of pediatric brain tumours. 
This is due to the fact that there are few studies that utilize clinical outcome measures to assess 
whether or not these survivors show ongoing quasi-static and dynamic standing balance difficulties. To 
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date, most of the studies conducted with this population use laboratory based measures but these tools 
are often not available in the clinical setting.
10-14
 
Another issue surrounding the lack of continued rehabilitation in survivors of pediatric brain 
tumours is that the association between balance abilities and quality of life remains unknown. It can be 
postulated that difficulty in maintaining quasi-static or dynamic standing balance may lead to difficulty 
performing certain motor tasks or functions that could in turn affect quality of life. This could further 
emphasize the need for continued physiotherapy follow-up of these patients. It would be interesting to 
verify if there exists a relationship between balance abilities, as assessed by the tools regularly used in 
physiotherapy, and health-related quality of life as this is very rarely measured in the clinical setting. 
This thesis will hopefully shed some light into these issues that physiotherapists working with 
survivors of pediatric brain tumours face. I will begin with a review of the literature on pediatric brain 
tumours, long-term outcomes in survivors and the control of balance followed by the first manuscript 
presenting a structured review on balance abilities in survivors of pediatric cancers. Chapter 4 will 
outline the objectives and hypotheses of the research study while Chapter 5 will provide the 
methodology. In Chapters 6 and 7, I will present two other manuscripts, one that will present some key 
results while the second will highlight a specific part of the methods used for this research project. 
Additional results will be provided in Chapter 8 followed by a discussion in Chapter 9. The final 
chapter of the thesis will be a conclusion. 
 
 
 
 
 
Chapter 2: Literature Review 
2.1 Brain Tumours in Children and Adolescents 
2.1.1 Definitions and Trends 
Tumours of the central nervous system (CNS) represent the second most common form of 
pediatric cancer, after leukemia, and the most common solid tumour in children and adolescents.
15-19
 
CNS tumours can be described as a ―heterogeneous collection of neoplasms of different histology, 
behaviour and prognosis‖.19 In children and adolescents, nearly all CNS tumours are primary in origin, 
meaning that they arise in the CNS.
20
 The causes of brain tumours are not well known. There is some 
evidence that certain brain tumours may be attributed to a genetic predisposition and the only known 
risk factor for brain tumours is previous exposure to ionizing radiation.
18,21,22
 However, these factors 
account for only a small percentage of all brain tumours in the pediatric population.
6  
There are several trends that emerge with regards to pediatric brain tumour characteristics. The 
literature tends to suggest that males are slightly more affected than females as noted in several studies 
looking specifically at incidence rates. Bauchet et al. (2009) found that 52.4% of primary CNS 
tumours occur in males while Johannesen et al. (2004) found that 55.8% of CNS tumours occur in 
males.
15,23
 Some studies have also reported gender differences in incidence rates: Dreifalt et al. (2004) 
found an incidence rate of 5.26 cases/100 000 person-years for boys versus 4.5 cases/100 000 person-
years for girls.
16
 Kohler et al. (2011) report a less striking difference of 48.8/1 000 000 person-years 
for boys and 48.12/ 1 000 000 person-years for girls.
24
 Furthermore, various studies involving 
participants with pediatric brain tumours, a higher percentage of subjects tend to be male.
20  
Another trend that emerges from the literature is that a majority of pediatric brain tumours 
occur in the infratentorial region of the brain. This region, also known as the posterior fossa, is defined 
as the area of the brain that lies below the tentorium cerebelli and contains important structures such as 
the cerebellum and brainstem.
25
 The Central Brain Tumor Registry of the United States (CBTRUS), 
the largest, highest-quality, population-based database on brain tumours, reports that 28% of all 
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pediatric CNS tumours occur in the cerebellum (17%) or brainstem (11%).
7
 Arora et al. (2009) report 
similar findings of 30% of brain tumours in children aged 0-14 years old occur in the posterior fossa.
6
 
A few studies report even higher percentages of pediatric tumours occurring in the posterior fossa: 
Bauchet et al. (2009) report approximately 50%; Kadri et al. (2005) report 53% while Cho et al. (2002) 
report 39.1%.
15,26,27
 
 
2.1.2 Incidence 
Examining the literature, one notes that incidence rates vary by country and even by 
geographic regions within a given country. Comparison of incidence rates between studies can be 
difficult as specific registries have different requirements and methods of collecting data.
22
 For 
example, some registries include benign tumours while others only consider malignant brain tumours. 
Furthermore, the classification systems used by the various registries to categorize brain tumours are 
not always the same. 
The Canadian Cancer Society reports that between the years 2003-2007, 1039 CNS tumours 
were diagnosed in children and youth aged 0-19 years old, which represents the third most common 
form (16%) of pediatric cancer behind leukemia (26%) and lymphoma (17%).
1
 Incidence rates from 
the Canadian Cancer Society are reported to be 27/1 000 000 per year.
1
 The most recent report from 
CBTRUS, dated 2012, reports the incidence of CNS tumours to be 5.05/100 000 person-years in 
children and adolescents aged 0-19.
7
 Incidence rates are highest in the 0-4 age group with an incidence 
of 5.46/100 000 person-years.
7
 This peak is similar to findings in other studies that show a greater 
incidence in the 0-4 age range.
19,21,23,28
 The incidence rates reported by CBTRUS are slightly higher 
than those reported by several studies on European incidence rates. For example, Peris-Bonet et al. 
(2006) found an incidence rate of 29.9/1 000 000 children using the Automated Childhood Cancer 
Information System, a large European database.
19
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An area that is garnering lots of attention is whether or not the incidence rates of pediatric 
brain tumours are increasing. Several studies report an escalation in the incidence rates of CNS 
tumours in the pediatric population.
16,22,23,28,29
 Some reports highlight a sharp rise in incidence of 
tumours during the mid-80s, which they attribute to the introduction of magnetic resonance 
imaging.
16,30
 These studies appear to be comprehensive as they analyze trends over several decades 
with data stemming from multiple sources. Others report that this increase is due to the changing of 
classification systems as well as the inclusion of benign brain tumours in registries.
22,30
 To date, there 
is little consensus as to whether or not the incidence of pediatric brain tumours is actually rising and no 
study has been able to empirically explain why these increases may be occurring. 
 
2.1.3 Presenting Signs and Symptoms  
The presenting signs and symptoms of brain tumours in the pediatric population vary 
according to the nature and location of the tumour, as well as the age of the child or adolescent.
31-35
 
Often signs are related to increased intracranial pressure, which can be attributed either to mass effect 
of the tumour on the brain or the tumour itself.
32,34
 A systematic review and meta-analysis done by 
Wilne et al. in 2007 found that the most frequent signs or symptoms upon presentation, regardless of 
tumour location, are headache (33%), nausea and/or vomiting (32%) and abnormal gait or coordination 
(27%).
36
 Several subsequent studies not included in the systematic review have also shown that these 
three symptoms are among the most common but also include visual problems such as papilloedema or 
abnormal eye movements.
31,33,37
 Many studies also show that the vast majority of children and 
adolescents will exhibit at least two of these symptoms upon diagnosis of the brain tumour.
37-40
 Other 
reported signs and symptoms from the meta-analysis include seizures, unspecified signs of increased 
intracranial pressure, squint, change in behaviour or school performance, macrocephaly, cranial nerve 
palsy, lethargy, hemiplegia, weight loss, focal motor weakness or altered level of consciousness.
36
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Because signs and symptoms of brain tumours vary according to location, tumours occurring 
in the posterior fossa tend to present in the same manner. Tumours affecting the cerebellum often 
present with increased intracranial pressure and/or hydrocephalus, causing headaches and vomiting or 
even macrocephaly.
32,33,41
 Other commonly reported signs and symptoms of cerebellar tumours include 
ataxia, incoordination, head tilt, cranial nerve palsy, gait changes or nystagmus.
32-34,41
 Brainstem 
tumours may additionally present with swallowing difficulties, hemiplegia or upper motor neuron 
signs.
34,41
 
 
2.1.4 Classification and Most Common Types 
A general classification system used, particularly in cancer incidence and survival studies, to 
categorize pediatric cancer is the International Classification of Childhood Cancer (ICCC). A separate 
system from adults was deemed necessary as it is believed that tumours in children and adolescents 
should be categorized by their morphology and not their location.
42
 In 2005, a third edition of the 
ICCC, the ICCC-3, was released.
42
 The ICCC-3 includes all types of cancer found in children and 
adolescents including leukemia, lymphoma and CNS tumours. One shortcoming of the ICCC-3 is that 
the subdivision of CNS tumours is quite limited with only 6 categories; however, these categories 
comply with World Health Organization (WHO) classification of tumours of the CNS, which is based 
on the pathology and genetics of tumours.
42
  
The WHO classification of CNS tumours was initially established in 1979, with the most 
recent 4
th
 edition published in 2007.
43
 This extensive classification system, based on tumour histology, 
is accepted and used worldwide, making international collaboration possible.
43
 Certain tumours are 
further graded into more benign or malignant categories, with low-grade tumours generally classified 
as WHO grade I or II, while WHO grades III and VI denote high-grade tumours.
43
  
Many epidemiological studies have been conducted in order to establish what the most 
frequent pediatric CNS tumours are and results between the studies are similar. Astrocytomas are the 
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most common, reportedly accounting for 25.7-47% of all brain tumours in childhood.
1,15,16,26,27,41,44
 This 
is followed by embryonal tumours (16-27.5%) and ependymal tumours (4.8-11.4%).
1,15,16,26,41,44
 Based 
on WHO histological classification, the most common specific type of brain tumours found in children 
and adolescents varies by age but overall, the most common are pilocytic astrocytomas followed by 
medulloblastomas, craniopharyngiomas and ependymomas.
6,7,21,26-28,38
 Interestingly, three of these four 
tumours are commonly located in the posterior fossa. Medulloblastomas occur exclusively in the 
cerebellum and are the most common malignant tumours in children and adolescents.
45
 Although not 
exclusively found in the cerebellum, pilocytic astrocytomas and ependymomas arise primarily in the 
posterior fossa.
46,47
 
 
2.1.5 Treatment and Acute Side Effects 
Treatment of pediatric brain tumours is dependent upon several factors including age, tumour 
histology and location and may include one or a combination of neurosurgical procedure, radiation 
therapy or chemotherapy.
20,48-50
 Treatment protocols for pediatric brain tumours are constantly 
evolving as many children and adolescents with CNS tumours are enrolled in clinical trials.
20,48
 Groups 
such as the Children’s Oncology Group, a large conglomerate of international centres treating pediatric 
brain tumours, conduct various trials in order to design effective therapies for tumours where survival 
is less than optimal or to design treatment protocols that minimize long-term effects on survivors.
20,48
 
As pediatric brain tumours overall remain rare, these consortiums exist in order to pool patient 
populations to have more substantial sample sizes.  
Often the first step in treatment of pediatric brain tumours is a neurosurgical procedure. 
Surgery may be necessary on an urgent basis if there is acute deterioration in a child or adolescent’s 
status due to either hydrocephalus or mass effect of the brain tumour itself.
20,48
 If the tumour is located 
in an area amenable to resection, the goal of neurosurgery is to determine histology and to reduce 
tumour volume, often referred to as ―debulking‖.20,35,51 Gross total resection of the tumour done as 
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safely as possible (i.e. without injuring normal brain tissue) is another aim as the extent of resection is 
highly prognostic.
48,49,52-56
 For certain tumours, such as pilocytic astrocytomas or other low-grade 
gliomas, surgery may be the only necessary treatment.
34,35,49-51,54,56,57
 
Complications may arise following neurosurgical resection of a brain tumour. Post-operative 
complications may include focal neurological deficits including weakness or sensory problems, 
perioperative stroke (hemorrhage or infarct), brain swelling or cerebrospinal fluid leak.
34,48,57,58
 
Hydrocephalus may also occur following resection of a brain tumour and may require more permanent 
solutions such as a third ventriculostomy or insertion of a ventriculoperitoneal shunt.
57,58
 Another 
significant sequela of neurosurgery, specifically after surgery involving the posterior fossa, is the 
development of posterior fossa syndrome also known as cerebellar mutism.
34,48,57,58
 Posterior fossa 
syndrome is characterized by delayed onset (1-6 days post-operative) of mutism that is often 
accompanied by emotional lability and other neurologic signs such as hypotonia, ataxia or 
hemiparesis.
59,60
 It has been reported to occur in up to 29% of those having undergone resection of a 
posterior fossa tumour.
59
 Posterior fossa syndrome can resolve in a matter of days or months and 
recovery is often spontaneous as there is little evidence supporting specific medical or therapeutic 
treatment; however, children and adolescents can be left with long-term speech difficulties such as 
dysarthria.
59,60
  
With regards to adjuvant treatment, radiation therapy is often used in the treatment of 
malignant brain tumours as well as unresectable benign tumours.
48,52,56
 Radiation therapy involves the 
delivery of high-energy beams to either a specific area of the brain or to the whole craniospinal 
axis.
20,48,52,61
 Recent improvements in technology have allowed for treatment to better target affected 
areas, minimizing damage to normal brain tissue.
20,35,48,50,52,61
 Medulloblastoma and ependymoma are 
examples of tumours where radiation therapy is part of the standard of care; however, for some 
younger children (i.e. those under the age of three years old) all efforts are made to delay radiation as 
there are well documented long-term effects on the developing brain that will be discussed later.
48-
9 
 
51,56,62
 Acute side effects of radiation therapy are often short lived and subside within a few days or 
weeks after radiation has stopped. These acute side effects include local skin reactions, anorexia, 
nausea, fatigue, local alopecia, otitis, myelosupression, low-grade headaches or acute 
encephalopathy.
34,48,61,63
 
The use of chemotherapy in the treatment of pediatric brain tumours is one that is continuously 
evolving as researchers attempt to establish the most effective protocols. A major challenge of 
chemotherapy for CNS tumours is the fact that agents used must be able to overcome the blood-brain 
barrier.
20,48
 There are several indications for the use of chemotherapy in the treatment of brain tumours 
including: attempting to slow the growth of low-grade tumours, use as an adjuvant to enhance surgery 
and/or radiation, to delay radiation in infants or young children or to be used concomitantly during 
radiation therapy to augment effectiveness.
20,51
 For some high-grade tumours, chemotherapy in 
conjunction with radiation therapy remains one of the best ways to prolong survival.
48,50-52
 The most 
commonly used chemotherapy agents are vincristine, etoposide, cisplatin, carboplatin, 
cyclophosphamide, lomustine, carmustine, methotrexate and temozolomide.
48,49,52
 There are many 
systemic side effects of chemotherapy including nausea, constipation, alopecia, encephalopathy and 
myelosupression.
34,48,58
 Some more focal side effects include peripheral neuropathy caused by 
vincristine, which can be either motor or sensory or mixed and is usually reversible once treatment is 
stopped.
34,48,64
 Another common focal side effect is irreversible ototoxicity and hearing loss caused by 
cisplatin or carboplatin.
34,48,64
 
 
2.2 Surviving a Brain Tumour 
 2.2.1 Survival and Recurrence Rates 
According to the most recent statistics from the Canadian Cancer Society, the overall five-year 
survival rate for primary CNS tumours in Canadian children and adolescents is 71%.
1
 These rates are 
comparable to those reported by larger scale databases in Europe and the United States where overall 
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survival rates range from 64% to over 70%.
19,30,65
 In the literature there is a tendency for studies to 
show that children diagnosed under the age of three or four years old have a less favourable prognosis, 
although this is not always statistically significant, with those diagnosed in infancy (i.e. < one year old) 
having the worst prognosis.
19,30,66,67
 With regards to time trends, there has been an unquestionable 
improvement in overall survival rates of children and adolescents with CNS tumours.
19,24,30,67
  
Tumour type, along with age, plays a significant role in survival rates and reports demonstrate 
a marked difference in survival among various diagnostic groups.
22
 In order to simplify the discussion, 
only the most common forms of pediatric CNS tumours as described above (i.e. astrocytoma, 
medulloblastoma and ependymoma) will be focused on. Even within a given tumour histology, 
outcome varies. For example, low-grade astrocytomas such as pilocytic astrocytoma have been 
described as having very successful 5-year survival rates ranging from 81-97%.
1,24,66,68-71
 On the other 
hand, high-grade astrocytomas, such as glioblastoma, have more abysmal survival that is frequently 
described in the literature as 2-year (as opposed to 5-year) rates ranging from 29-32%.
66,71-73
 Survival 
rates for medulloblastoma, the most common malignant pediatric brain tumour, have greatly improved 
over the last decade, now ranging from 41.4-80%.
24,30,66,68,71,74
 This variability in rates can likely be 
attributed to the fact that patients with medulloblastoma are divided into two different risk groups for 
therapy: standard risk (age>3 years old, residual tumour <1.5 cm
2
, no metastatic disease) or high risk 
(age<3 years, residual tumour >1.5cm
2 
and signs of disseminated disease) and not all reports make the 
distinction between the two groups when reporting survival.
45
 Finally, for the third most common 
tumour histology, ependymoma, survival rates also vary depending on sub-type but are generally 
reported to be between 64.9-72%.
1,66,75,76
  
It is more challenging to find literature reporting specific recurrence rates for pediatric CNS 
tumours. Many reports are case studies or series and/or focus on treatment of recurrent CNS tumours 
without noting actual percentages. There is no mention of recurrence rates in the larger reports 
stemming from the more extensive databases such as CBTRUS. Furthermore, many studies report 
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progression-free survival, defined as "time from diagnosis to the date of progression or date of 
death".
77
 Although the definition does vary slightly depending on the report, progression-free survival 
may not reflect true recurrence as the cause of death for each subject is generally not established in 
studies and cannot be directly attributed to tumour recurrence or progression.  
Even though the literature is sparse, there are several reports looking at recurrence rates in 
low-grade glioma and astrocytoma. This is likely owing to the fact that survival rates are higher in 
these tumours and medical teams need to know how frequently to monitor these children and 
adolescents for recurrence once their treatment is completed. One study describing outcomes in 361 
children diagnosed with low-grade glioma between 1985-2007 reports progression of primary tumour 
in 38% of patients.
77
 Two other studies report recurrence rates of 7% and 44% for low-grade 
astrocytoma, demonstrating inconsistent rates.
69,78
 Direct comparison of these rates is problematic 
owing to the differing practices in various centers regarding treatment protocols and information 
maintained in their databases, which likely contributes to the variability of the rates reported in the 
literature. However, one commonality between many studies is that recurrence tends to occur more 
frequently in those with only partially resected tumours as compared to those where gross total 
resection is achieved.
69,70,79
 
 
2.2.2 Long-term Outcomes 
As survival continues to improve after diagnosis of pediatric CNS tumours, there is a growing 
interest in studying the long-term outcomes of this population. Late-effects may be due to the tumours 
themselves or to the effects of its treatment on the developing brain. Much effort in recent years has 
gone into investigating what domains may be affected in the long-term in these survivors. 
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2.2.2.1 Physical Outcomes 
Late-effects of treatment on physical and functional outcomes of survivors of pediatric CNS 
tumours is an area where there is a smaller amount of literature available compared to other domains 
such as cognitive status. Many of the available studies report physical and functional deficits based on 
physician assessment or via subjective questionnaires. In fact, very few studies use standardized, 
objective outcome measures to assess physical functioning in survivors of pediatric CNS tumours. 
Nonetheless, it remains interesting to examine the available literature.  
Of the studies that employ subjective reports, three of the four reports stem from the 
Childhood Cancer Survivor Study (CCSS).
2,3,80
 The CSSS is a large-scale epidemiological follow-up 
study of survivors (five years or longer) of childhood cancer, consisting of 26 collaborating institutions 
in the United States and Canada.
81
 All three of these studies utilized a 24-page questionnaire to collect 
data and compared results to a randomly selected group of siblings, who are also included in the CCSS 
cohort as a control group. Therefore, it is quite likely that these three studies present data with the 
same participants. One of these studies investigated late-effects in physical performance in survivors of 
all forms of childhood cancer and found that survivors of CNS tumours had the greatest risk for 
performance limitations as well as the highest prevalence of participation restrictions compared to both 
the control groups of siblings and survivors of other forms of pediatric cancer.
80
 Both of these concepts 
(performance limitations and participation restrictions) are abstract and although there was an attempt 
to quantify them in a systematic manner, neither is well defined in the article. The other two studies 
specifically investigated survivors of pediatric CNS tumours and found that participants were more 
likely to report new onset of weakness in arms and legs and coordination or motor problems than the 
sibling control group.
2,3
 The final study using subjective reports to obtain data on physical outcomes in 
21 participants found that 8 (38%) had limb ataxia (with 5 of the 8 participants reporting that it limits 
their daily life), 6 (28.5%) had truncal ataxia (with 3 out of 6 participants reporting that it limits their 
daily life) and 4 (19%) complained about frequent headaches.
82
 But there is no information on how 
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ataxia was described to participants and what their understanding of ataxia is. So although all these 
studies report that survivors of pediatric CNS tumours have some deficits in physical functioning, the 
results are very general in terms of the severity and types of impairments.  
Studies utilizing physician-reported outcomes may not be better at providing information on 
the long-term effects of CNS tumours and their treatment in this population. Very few standardized 
measures are reported; therefore, the methods for describing the impairments are liable to vary 
between physicians. For example, in the studies where physicians assessed ataxia in survivors, 
methods of assessing and classifying ataxia are not presented.
83-85
 Although comparison may be 
inappropriate, rates of ataxia range from 14.5-30.4% in these studies where the sample sizes are small 
and the timing of the evaluations post-treatment is not the same. Similarly, another abstract concept 
physicians assess is motor problems. There is no widely accepted definition of what constitutes a 
motor problem or deficit and often studies utilize a self-made classification system where criteria are 
quite general. For example, in a study by Macedoni-Lukšič et al. (2003), they attempted to grade motor 
impairment into categories based on the presence of hemiparesis or ataxia (either graded as mild, 
moderate or severe) and on cranial nerve function.
86
 Other studies use broader categories such as motor 
problem or abnormal gait without noting any specific criteria used.
75,84,87
 Nonetheless, these studies 
report that motor dysfunction is found in 20.3-56% of their study samples but, as was the problem with 
the subjectively reported studies, sample sizes are small and time post-treatment that participants are 
evaluated is not always specified.
75,84,86,87
 Although not well defined, according to these studies, it does 
appear that survivors of pediatric CNS tumours continue to show some form of motor or neurological 
impairment even up to 30 years after treatment.  
Reports that make use of standardized outcome measures to quantify physical outcomes may 
be more meaningful in that they can objectively describe level of functioning. But studies are very 
variable and direct comparison becomes impossible owing to different inclusion criteria and the 
assortment of measures used. One of the most comprehensive studies found, conducted by Ness et al. 
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(2010), evaluated 78 survivors of pediatric brain tumours compared to a control group matched for 
age, gender and zip code.
88
 Although no specific conceptual framework was elaborated, the study 
participants were evaluated on a multitude of objective measurements comprising what the authors felt 
were different facets of physical functioning including: touch sensation using a 5.07 Semmes-
Weinstein monofilament (the threshold for loss of protective sensation), hand grip and knee extensor 
strength using hand-held myometry and several standardized tests: Physical Performance Test, Berg 
Balance Test and Functional Status Index.
88
 They found significant differences between the two groups 
on all these measures, indicating poorer physical functioning in the multiple areas assessed.
88
  
Conversely, the other studies used only one objective measure. Two studies used the 
Karnofsky Performance Status Scale, a tool that quantifies the functional status of cancer patients on a 
scale from 0 (dead) to 100 (normal functioning).
89
 In both of these studies, 73% of participants had no 
complaints, functioned normally and were considered independent for daily life.
78,90
 Another study 
investigating motor function using the Bruininks-Oseretsky Test of Motor Proficiency - 2
nd 
edition 
(BOT-2) in 15 participants with  cerebellar tumours diagnosed before the age of five years old, found 
that 47% showed significant impairment in at least one of the subcategories on the BOT-2 and 40% 
showed significant impairment in the overall score.
91
 However, none of the participants’ scores were in 
the range denoting clinical impairment though they were very close.
91
 Rueckriegel et al. (2009) used 
two fine motor tasks examined via kinematic analysis in a group of 41 survivors with cerebellar 
tumour (25 with medulloblastoma and 16 with pilocytic astrocytoma) as compared to a control group 
matched for age and gender.
92
 Results showed that survivors of medulloblastoma demonstrated 
impairment in the parameters of speed, automation and variability in the tasks of writing a sentence 
and drawing circles while survivors of pilocytic astrocytoma showed impairments only for the writing 
task in the speed and automation parameters.
92
 A final study using the Finger Tapping Test, which 
measures motor speed, found impairments in 69-77% of 16 10-year survivors of childhood 
medulloblastoma.
93
 Although we cannot directly compare results of these studies, they tend to 
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demonstrate that survivors of pediatric CNS tumours have multiple areas of difficulty in physical 
functioning.  
Several studies, regardless of how data was collected, try to link certain patient characteristics 
and tumour or treatment variables to physical outcomes in order to predict who may have difficulties. 
Results are conflicting. For example, a pair of studies finds a significant association between adjuvant 
treatments received and motor performance.
3,91
 One found that poorer motor performance was 
associated with both chemotherapy and radiation therapy while the other found poorer results only in 
those survivors treated with radiation therapy.
3,91
 Other studies do not find any significant associations 
between either of these factors.
78,90
 Similar contrasting results are shown when looking at the 
associations between age at diagnosis and motor performance, with certain studies showing poorer 
performance in those diagnosed at a younger age.
88,90,92
 Other studies demonstrate no significant 
correlation between age at diagnosis and motor outcomes.
78,91
 One reason that some of these studies 
may not show significant results could be attributed to the small sample sizes of many of the reports. 
Thus, there may be actual associations between patient characteristics and treatment or tumour 
variables and physical impairments in survivors of pediatric CNS tumours, but the literature at this 
time does not provide sufficient empirical evidence to support this. 
 
2.2.2.2 Cognitive and Academic Outcomes 
Contrarily to physical outcomes, long-term cognitive outcomes are well documented in 
survivors of pediatric CNS tumours. There is so much literature that a large-scale meta-analysis was 
done in 2010 describing neurocognitive sequelae in survivors of pediatric CNS tumours.
4
 A total of 39 
studies, published between 1992-2009, combining data from 1 318 children were used for the 
calculations in several domains of neurocognitive functioning.
4
 Survivors showed significant deficits 
compared to normative data in the areas of overall cognitive ability, verbal intelligence, non-verbal 
intelligence, academic achievement, attention, psychomotor skill, visual-spatial skill, verbal memory 
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and language as assessed by various standardized tests.
4
 Effect sizes varied from small to large 
depending on the domain.
4
 The authors stated that they were unable to analyze for potential predictors 
or moderating factors as they relate to cognitive performance due to the differing inclusion criteria of 
the studies.
4
 Sample sizes of the included studies varied from 4 to 133 participants as did the time post 
diagnosis or treatment for survivors although the majority of studies evaluated participants three years 
after diagnosis.
4
  
Studies that were not included in the meta-analysis or that were published after the time period 
for the search, demonstrate similar results. Most studies investigating cognitive outcomes use a version 
of the Wechsler Intelligence Scale for Children, which has been translated into several languages, 
available for different age ranges, undergone several revisions and is available in an abbreviated 
version. Many of the studies will describe several domains of the test but all of them will report an 
intelligence quotient (IQ) derived from this tool. Several studies demonstrate that the IQ for survivors 
of pediatric CNS tumours tends to be significantly lower than the normative range but not at levels 
where they would be classified as having an intellectual impairment.
77,94,95
 Further studies showed that 
their sample had lower IQ scores (or a greater proportion scored in the lower range compared to the 
normal population) but was not statistically significant.
90,96,97
 It would be interesting to add these 
studies to the aforementioned meta-analysis to help strengthen the results.  
There is further interest in evaluating cognitive function over time to determine whether there 
is an overall decrease, as is hypothesized by many researchers. Only three studies were found that 
specifically look at neurocognitive function over several time periods after treatment for pediatric CNS 
tumours. Sample sizes of these studies are small, ranging from 26-35 participants, each study 
investigates a different tumour type and all studies use a version of the Wechsler Intelligence Scale for 
Children.
98-100
 One study reveals a decline in overall age-adjusted IQ over time since administration of 
radiotherapy.
99
 On the other hand, the two other studies reveal stable IQs in survivors of CNS tumours 
over time.
98,100
 Another commonly held belief is that children who are diagnosed and treated at a 
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younger age are more at risk of cognitive deficits. Two studies were found that specifically 
investigated neurocognitive function in survivors of pediatric CNS tumours who were diagnosed 
before age three in one study and before age five in the other.
87,91
 In the study done by Fouladi et al. 
(2005) involving participants diagnosed with malignant CNS tumours before age three, significant 
declines in IQ were found over time, notably in participants who had undergone craniospinal 
irradiation.
87
 Davis et al. (2010) demonstrated that children diagnosed with cerebellar tumours under 
the age of five had lower overall cognitive scores compared to normative data but that these scores did 
not fall within the range denoting significant clinical impairment.
91
 
Overall, it would appear that neurocognitive function, most often reported as IQ, is 
significantly impaired in survivors of pediatric CNS tumours regardless of age at diagnosis or tumour 
type. The question then becomes, what impact does this have on their academic outcomes? Several 
studies investigate this question. One indicator of academic proficiency these studies employ is the use 
of specialized educational services. Multiple studies examine this and report that 22-90% of survivors 
of pediatric CNS tumours require specialized educational services.
2,86,87,93,96,97
 Although this represents 
a large range, it still appears to be a significant proportion of survivors that require additional support. 
To further highlight educational outcomes, some studies also explore the highest level of education 
attained by survivors of pediatric CNS tumours. Two studies report that 75% and 54% receive their 
high school diploma.
86,96
 The numbers significantly drop off for those who finish community college 
or university, reported in two studies as 3% and 20%, which is much lower than general population 
norms (53% in Canada).
86,96,101
 Vinchon et al. (2011) noted that 58% of survivors of pediatric CNS 
tumours completed high school or higher education without distinguishing between the levels of 
education.
90
 In the only study employing a control group, Armstrong et al. (2009) found that siblings 
of survivors of pediatric CNS tumours were more likely to graduate from college.
102
 Even though most 
will require special assistance along the way, it appears that many survivors of pediatric CNS tumours 
are able to obtain a high school diploma and some attain higher levels of post-secondary education. 
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2.2.2.3 Behavioural and Social Outcomes 
When describing behavioural and social outcomes in survivors of pediatric CNS tumours, 
constructs that are not always well defined, it becomes difficult to separate the two as they are 
inextricably related. The Child Behavior Checklist, a parent-report measure of psychosocial 
functioning in children between the ages of 4-18 years appears to be the most widely used outcome 
measure to evaluate these constructs.
103
 There is also a self-report version called the Youth Self-
Report.
103
 A review article written by Schulte & Barrera (2010) discussed social outcomes in survivors 
of pediatric CNS tumours, focusing on reports published between 2000-2009.
5
 Half of the twenty 
studies included in the review use the Child Behavior Checklist while three more use the Youth Self-
Report.
5
 Overall, most studies demonstrate compromised social competence, specifically in what the 
authors describe as social adjustment, in survivors as compared to normative data or to a control group 
when used.
5
 The review article also investigated if any of the included studies evaluated associations 
between participant characteristics and treatment to social outcomes and found that the evidence 
supports that disease recurrence and longer time since diagnosis are related to lower social 
competence.
5
 Additional studies found in the literature that were not included in the review did not 
demonstrate the same behavioural and social difficulties. For example, a study by Zuzak et al. (2008) 
found that 4 out of 15 participants (26%) evaluated by the Youth Self-Report had clinically significant 
deficits and 1 out of 9 survivors (11%) had clinically significant deficits as reported by parents using 
the Child Behavior Checklist.
82
 Similarly, another study evaluating 54 survivors of pediatric CNS 
tumours found significant deficits in only the internalizing sub score of the Child Behavior Checklist 
as compared to normative values but did not discuss how this related to social competence.
104
  
Another assessment tool found in the literature that is used to quantify behaviour in survivors 
of pediatric CNS tumours is the Behavioral Assessment System for Children, a questionnaire with self-
, parent- and teacher-report versions.
105
 This tool does not appear to be as widely used as only two 
studies employ it to quantify social competence and behavioural problems. One study used the 
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Behavioral Assessment System for Children in 32 adolescents who were at least one year off treatment 
for a brain tumour and found that they were not at a greater risk for problems compared to normative 
values.
105
 Similarly, the other study employing this questionnaire with parents of 25 children treated 
for malignant brain tumours found all scores to be within normal limits.
106
 The Behavioural 
Assessment System for Children may be less widely used as its psychometric properties have not been 
evaluated in this population so it may be less sensitive to difficulties in social competence in survivors 
of pediatric CNS tumours.  
Interestingly, the only two studies found that employ a control group when investigating social 
and behavioural outcomes in survivors of pediatric CNS tumours do not use typically-developing 
children and adolescents but a patient control group. One study uses children and adolescents with 
juvenile rheumatoid arthritis as a control group when evaluating facial expression recognition.
107
 
Results of this study showed that survivors of pediatric CNS tumours made significantly more errors in 
recognizing facial expressions than children with juvenile rheumatoid arthritis.
107
 The authors feel this 
method may be an objective way to evaluate social competence but do not suggest that it fully assesses 
the construct.
107
 The other study used a group of survivors of leukemia as the control group and found 
that CBCL scores were within normal limits compared to norms and there were no significant 
differences between survivors of pediatric CNS tumours and survivors of leukemia.
108
 Overall, it 
seems that social and behavioural difficulties may be present in survivors of pediatric CNS tumours, 
but as these constructs are very vague, definitions need to be standardized and more objective outcome 
measures need to reflect this definition. 
 
2.2.2.4 Health-Related Quality of Life 
There is a growing body of literature on health-related quality of life (HRQOL) in survivors of 
pediatric CNS tumours. This can be attributed to the fact that the medical community is interested in 
the impact that increased survival rates in this population have had on HRQOL. The current literature 
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does not offer any conclusive results. Most of the studies compare their participants’ scores to 
published norms as opposed to using a control group. Furthermore, of the ten studies retrieved that 
report HRQOL, nine different outcome measures are used. Some of these measures have had their 
psychometric properties tested while others have not as they were specifically developed for that 
particular study. Therefore, before researchers begin assessing HRQOL in survivors of pediatric CNS 
tumours, it may become more important to establish valid and reliable tools.  
Results from studies are highly variable. Some report significantly lower HRQOL in survivors 
of pediatric CNS tumours.
75,109
 An additional study, that did not provide statistical analysis, 
demonstrated a trend for lower HRQOL scores in survivors compared to normative data.
2
 There are 
some studies that show that survivors of CNS tumours rate their HRQOL similar to published 
norms.
93,106,110
 One of these, conducted by Cardarelli et al. (2006), is one of the few that employs a 
control group.
110
 They used the Health Utilities Index to assess HRQOL and the control group 
consisted of survivors of either acute lymphoblastic leukemia (ALL) or solid tumours located outside 
the CNS.
110
 Results showed no significant differences in HRQOL between any of the groups.
110
 
Divergent to all the above mentioned results, there are two studies that demonstrate that survivors of 
pediatric CNS tumours rated their HRQOL higher than published norms.
82,111
 This is completely 
counter-intuitive; however, neither of these studies proposed a clear explanation for this phenomenon. 
Interestingly, both focused exclusively on survivors of low-grade tumours.
82,111
  
Unfortunately, it is difficult to draw specific conclusions from some of the studies with regards 
to HRQOL. One such study conducted by Reimers et al. (2009) evaluated 126 survivors of pediatric 
CNS tumours with no control group using a HRQOL tool, the Minneapolis-Manchester Quality of Life 
questionnaire.
112
 The authors used an early version of the tool that had not been fully developed and 
had been translated to Danish without any norms or testing of its psychometric properties.
112
 The aim 
of their study was to look for potential risk factors related to HRQOL but they did not report or 
comment upon overall scores.
112
 They concluded that lower IQ is a strong determinant for HRQOL, 
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but this may not necessarily be meaningful if HRQOL was not compromised in their participants.
112
 
Another study by Odame et al. (2006) evaluated osteopenia, physical activity and HRQOL in a group 
of 25 survivors of pediatric CNS tumours with no control group.
113
 They were primarily interested in 
the prevalence of osteopenia in their sample and tried to see how the outcomes listed associated with 
radiation therapy treatment.
113
 Results of HRQOL were not compared to norms and although not 
significant, they found a trend that HRQOL was higher in those participants who had not received 
radiation therapy.
113
 But as with the above study, as there was no mention of how their scores 
compared to norms or a control group, it is difficult to draw specific and meaningful conclusions.  
To conclude, the evidence is conflicting with regards to HRQOL in survivors of pediatric CNS 
tumours. Studies demonstrate either worse, the same or better HRQOL as compared to published 
norms or to a control group when used. As previously mentioned, it will likely be necessary to develop 
tools that are valid and reliable to measure HRQOL in this population. This is the only way to truly 
assess how the improved medical management and survival rates in children and adolescents with 
CNS tumours affect their HRQOL. 
 
2.3 Balance 
2.3.1 Definitions 
 The two main functions of the postural control system are to maintain postural orientation and 
postural stability.
114
 On one hand, postural orientation can be thought of as sustaining the alignment of 
body segments in relation to a one's environment.
114,115
 On the other hand, postural stability, more 
commonly referred to as balance, is defined as "the ability to maintain the centre of mass (COM) 
within the limits of the base of support (BOS)".
114
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2.3.1.1 Quasi-Static Postural Stability  
 Quasi-static postural stability refers to a person's ability to maintain a stationary position.
114,115
 
Although the body is stationary, many studies have demonstrated that during quiet standing there are 
many small oscillations of the COM.
114
 This is known as body sway and is often estimated from the 
centre of pressure (COP), which is described as the location of the vertical ground reaction force acting 
upon the COM.
114,116
 One mechanism proposed for the control of upright posture is the inverted 
pendulum model, whereby the body sways about the ankle joints.
117
 In this model, Winter et al. state 
that the difference between the location of the COM and the COP is proportional to the acceleration of 
the COM, which oscillates during quiet standing.
117
 This model forms the basis of many studies 
involving kinetic analysis of balance or dynamic posturography, which will be discussed later. 
 
2.3.1.2. Dynamic Balance 
 Dynamic balance refers to how a person maintains their postural stability either during 
movement or in response to perturbations.
114
 In these circumstances a person may use both feedback 
and feed-forward mechanisms in order to maintain balance.
114,115,118,119
 Feedback mechanisms, 
sometimes referred to as reactive postural adjustments, are thought to be the only ones available when 
dealing with unexpected postural perturbations.
115,118-120
 These reactive postural adjustments include 
reactions such as the ankle, hip and stepping strategies.
114
 On the other hand, feed forward control, also 
known as anticipatory postural adjustments (APA), refers to the preparations to postural control that 
occur prior to expected movements or perturbations.
114,115
 It is believed that feedback information from 
previous experiences also contribute to these APAs.
118,120
 
 
2.3.2 Neuroanatomy and Systems Involved 
 The exact way in which balance is controlled in humans is not completely understood. It 
involves many different parts of the human anatomy as well as the multiple connections between them. 
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Three of the most important and well-known peripheral systems for balance are the visual, vestibular 
and somatosensory systems.
114
 These systems provide information about where a person's body is in 
space thereby giving direction as to whether postural adjustments need to be made.
114,121
 A very brief 
overview of each system will be provided. Studies have demonstrated that the visual system is heavily 
relied upon by children in order to maintain balance.
122-125
 Vision allows for people to know the 
orientation of their head and body within their environment.
114,126
 Although vision is heavily relied 
upon, it not always necessary, as demonstrated by the fact that people can maintain their balance even 
in the absence of visual input. The parts of the vestibular system that contribute to balance are the 
semicircular canals and otoliths.
114,121,126
 These sensors provide information regarding the acceleration 
and linear position of the head.
114,121
 Finally, the somatosensory system, comprised of proprioceptive 
and cutaneous sensors including muscle spindles, Golgi tendon organs, joint receptors, nociceptors and 
thermal receptors, provides additional information regarding body position and movement.
114,121,126
 The 
control of balance requires the integration of all the information provided by these sensory systems. 
Under differing balance conditions, the reliance on each system varies and these multiple inputs are 
integrated. 
Several areas of the brain are thought to be involved in the control of balance; none more 
extensively studied than the cerebellum.
8,9
 Many studies have shown that different areas of the 
cerebellum assist in different aspects of balance.
9,127-129
 For example, the more medial parts of the 
cerebellum are thought to the most important for the control of balance.
127,129,130
 This is due to the fact 
that multiple afferent connections arrive from the visual and vestibular systems as well as the dorsal 
and ventral spinocerebellar tracts, so it is believed that sensory information is integrated there.
8,9,127
 To 
further support this, studies investigating cerebellar lesions in patients have found that those with 
midline lesions demonstrate worse balance abilities than those with lesions in other areas of the 
cerebellum.
9,10,131,132
 Furthermore, an emerging concept with regards to the role of the cerebellum is its 
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importance to the motor learning aspect of balance control.
9,128,129
 It is believed that the cerebellum, 
together with the motor cortex, helps finesse APAs based on trial-and-error practice.
9,128,129,133
 
Other brain structures involved in the control of balance are the basal ganglia.
8,128,133-135
 Less 
studied than the cerebellum, the exact mechanisms as to how the basal ganglia contribute to balance 
are unknown. Much of what is known stems from studies involving patients with lesions of the basal 
ganglia, notably those with Parkinson's disease.
8,135
 Visser et al. (2005) suggest that the basal ganglia 
play a role in the fine tuning of responses to postural perturbations, the running of simultaneous motor 
programs and sensorimotor integration.
135
 Furthermore, after conducting a literature review, Ioffe et al. 
(2007) assert that the basal ganglia play an important role in the learning of postural control, although 
no mechanism is clearly proposed.
128
 It is known that the basal ganglia receive inputs from the cerebral 
cortex, including the motor cortex, with projections to the brainstem and spinal cord, which may 
support these suggestions.
8,135
 A study by Goble et al. (2011) utilizing functional magnetic resonance 
imaging (fMRI) demonstrated activation in different areas of the basal ganglia when healthy 
participants were performing various tasks wherein balance was challenged.
134
 
Lastly, an emerging area of research pertains to the role of the cerebral cortex in the control of 
balance but, as was the case with the basal ganglia, the mechanisms are not well understood. Various 
areas of the cortex contribute in differing ways. For example, the visual cortex is involved in the 
processing of visual information, therefore assisting in maintaining balance.
8,130
 Several studies using 
either fMRI or other similar imaging techniques have shown activation in the parietal, sensory and 
motor cortices during different balance tasks.
134,136,137
 Recent research has also focused upon the role of 
the pre-frontal cortex in the control of balance. It is believed that the pre-frontal cortex is involved in 
the regulation of postural responses, notably APAs.
8,133
 This is supported by a study by Mihara et al. 
(2008) where functional imaging showed early activation of the pre-frontal cortex in response to 
"warned" perturbations.
136
 This has led to increased interest of studying the effects of attentional 
demand on balance, what is also known as dual-task performance.
138
 These studies often employ 
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different balance tasks combined with cognitive ones and several have been conducted in typically-
developing children and adolescents.
139-142
 All studies demonstrate in one form or another that postural 
control is decreased when a cognitive task is added in all age groups.
139-142
 From the available 
literature, it does appear that cognitive tasks alter the control of balance in typically-developing 
children and adolescents, which would support the notion that the pre-frontal cortex plays a role. 
 
2.3.3 Development of Balance 
 One of the earliest papers on the development of balance was written by Forssberg and 
Nashner in 1982.
143
 Based on their study using kinetic analysis and electromyography (EMG), they 
found that younger children produced larger and more variable APAs than older children and adults 
and that younger children demonstrated larger postural sway under altered sensory input.
143
 They 
suggested that the age of 7 ½ years old represents a turning point in balance control, whereby after this 
age it becomes similar to an adult's.
143
 This assertion has been supported by other researchers. For 
example, in several papers, Assaiante et.al (2005, 2012) discuss previous research conducted by their 
group where children around the ages of 7-8 years old begin to adopt a head stabilization strategy 
similar to adults when balance becomes more difficult.
144,145
 They also assert that children at age 7 
begin to be more selective in terms of the postural strategies that they use.
145
 However, they do admit 
that adolescence is a period where balance mechanisms are still undergoing a maturation process, 
notably in the integration of sensory information.
144
 Similarly, Barela et al. (2003) found that although 
the coupling of sensory information from visual and proprioceptive systems is adult-like in children at 
age 6, it has not matured to adult levels by 8 year old (the oldest age investigated).
146
 Another study by 
Girolami et al. (2010) investigating APAs in reaching tasks using kinetic analysis and EMG data found 
that COP displacement and timing of muscle activation patterns were similar between children older 
than 7 years old and adults but only had a sample size of 10 participants.
147
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There is literature that challenges this assertion that 7 years old represents a turning point in 
the development of balance, many of them investigating sensory systems. Hirabayashi and Iwasaki 
(1995), investigated 112 typically-developing children and adolescents and found that various sensory 
systems matured at different times.
148
 Notably, they found that visual function reached adult levels at 
14-15 years old and that vestibular function had not yet reached adult levels at 15 years of age, the 
oldest age included in the study.
148
 Similarly, based on their results, Nolan et al. (2005) suggest that the 
visual control of balance is still undergoing maturation at 15-16 years of age.
149
 Interestingly, Viel et 
al. (2009), from results of their study comprising of 20 participants between the ages of 14-15 years 
old, propose a theory where adolescents neglect proprioceptive information during balance tasks.
125
 
This theory was based on the fact that adults were better able to stabilize various body segments in 
response to postural perturbations and that adolescents relied mostly on vision.
125
 Finally, Sparto et al. 
(2006) more specifically investigated the integration of sensory information in a group of children 
between the ages of 7-12 years old and found that the weighting of the information does not reach 
adult levels.
124
 
Other studies refuting that the age of 7 years old represents a turning point in balance control 
report data on COP parameters. Two studies investigated static balance with trials of eyes open and 
eyes closed.
150,151
 Both studies found that children at age 10 years old have higher maximal excursion 
of COP and COP velocity as compared to adults.
150,151
 Furthermore, Schmid et al. (2005) propose that 
the transition period for balance control occurs between 9 -11 years old.
151
 Finally, another study 
investigated responses to postural perturbations leading to a fall noted differences in the activation 
pattern of muscles between adolescents aged 14 years old and adults.
152
 Therefore, although all studies 
tend to agree that the control of balance continues to mature throughout childhood and adolescence, 
the turning point where responses become similar to adults is still debated. 
The literature also seems to support the notion that the control of balance continues to mature 
as a child gets older and is subjected to different environments that challenge balance. However, 
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directly comparing studies investigating the development of balance can be challenging. This is due to 
the fact that the aims and subsequent study designs, tasks and variables, vary immensely between 
studies as well as the ages represented by the sample. 
With regards to sensory integration, studies have shown that children as young as 4 years old 
are able to take multiple sensory inputs and place differing importance on each one in order to control 
balance.
146,148,153
 However, these studies also demonstrated that this sensory reweighting is not refined 
at this age and continues to improve throughout childhood and adolescence.
124,146,153
 It is not known at 
exactly what age this sensory integration becomes adult-like.
124,148
 
In terms of development of the control of balance, several studies investigate how static 
balance evolves in children and all utilize COP parameters to describe balance abilities.
149,150,154
 Two 
of these studies, with similar methodology, found that older children and adolescents demonstrated 
decreased COP excursion and velocity, indicating improved control of balance.
149,150
 However, 
Lebiedowska and Syczewska (2000) found contrasting results.
154
 They evaluated children aged 7-18 
years old in quiet standing with eyes open and found no changes in any COP parameters over the age 
groups.
154
 This difference could be attributed to the fact that the first two include an eyes closed 
condition and may offer more of a challenge to balance than the eyes open condition.
149,150
 However, 
Nolan et al. (2005) did report differences in sway parameters in the eyes open as well as the eyes 
closed conditions.
149
 
Studies investigating the development of the control of dynamic balance mostly examine 
responses to postural perturbations. Two studies, by the same group of researchers, included infants as 
young as 9 months old among their sample and both had the children stand on a force platform that 
was subjected to unexpected backwards translations.
155,156
 One of these studies examined COP 
parameters as well as EMG data and divided participants both by developmental level (i.e. stander, 
new walkers, etc...) and by age group.
156
 They found that younger children had stronger distal 
activation patterns and delayed activation of more proximal muscles (i.e. hip abductors and 
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hamstrings).
156
 As they get older, children show increased activation of proximal muscles as well as 
the paraspinals.
156
 Finally, they concluded that developmental level may be a more appropriate way to 
predict balance improvement as compared to chronological age.
156
 The other study including 9 month 
old infants, undertook kinematic and kinetic analysis of their participants, whom they divided into 
groups based on developmental level.
155
 They found that even the most developmentally immature 
participants were able to maintain balance under minimally disturbing perturbations, indicating some 
rudimentary form of balance skills.
155
 Furthermore, they found that the various developmental levels 
displayed differing patterns of torque adjustments to perturbations and concluded that as a child gains 
motor skills and interacts with their environment, they refine their balance responses.
155
 
The next set of studies investigated children beginning at ages 3-4 years old. Do and Chong 
(2008) compared responses in children between the ages of 4-14 years old and in adults in a situation 
where a fall was triggered using EMG and kinetic data.
152
 They found that children showed co-
activation of soleus and tibialis anterior muscles in response to fall initiation while adults showed 
alternating contraction of these muscles.
152
 Unfortunately, they did not report responses between the 
various age groups to investigate how they evolved.
152
 Another study investigated APAs under either 
self-initiated or externally imposed perturbations.
118
 They found that all participants shifted their COP 
backwards after the postural disturbance, more so in the externally generated perturbations and that 
this difference between the two conditions decreased as participants got older.
118
 They concluded that 
feed-forward postural control is present in children as young as 3 years old and that the process refines 
as children age.
118
 Similarly, Girolami et al. (2010) found that children and adolescents between 7-16 
years old show direction-specific shifts in COP during specific arm movement tasks.
147
 However, the 
younger children in the study had less consistency in their EMG activation when compared to older 
children and adolescents but there were only 10 participants in this study so not all ages were 
represented in the same manner.
147
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Only one study was retrieved that attempted to longitudinally evaluate the same cohort of 
children and their development of balance control.
116
 They followed seventeen children beginning at 
age 5-6 years old and evaluated them at intervals of 3-4 months until the age of 8 years old.
116
 Static 
balance was assessed in the eyes open condition only and COP parameters were compared. Based on 
their results, notably changes in COP velocity, they suggest that balance develops in a non-linear 
fashion between the ages of 5-8 years old.
116
 So, although there is a plethora of literature describing the 
development of balance in children and adolescents, it appears to lack consensus. Furthermore, very 
few studies attempt to longitudinally assess participants, which may provide more meaningful insight 
into development trajectories of balance control. 
 
2.3.4 Evaluation of Balance in Pediatrics 
2.3.4.1 Clinical Balance Measures 
Evaluation of balance in the pediatric population can be challenging as tools need to be 
applicable to a variety of ages and developmental levels. They need to be easily understood by younger 
children and the items need to be challenging enough for the older children and adolescents. 
Unfortunately there is no gold standard for the evaluation of standing balance in the pediatric 
population. It is important for clinicians to have valid and reliable outcome measures in order to 
quantify standing balance in survivors of pediatric CNS tumours. However, there are no tools that have 
been specifically developed or that have had their psychometric properties tested in these children and 
adolescents. Several measures exist that have been developed for use in other patient groups with brain 
injury. For example, the Community Balance and Mobility Scale has demonstrated excellent reliability 
for children and adolescents who have sustained an acquired brain injury.
157
 The Balance Error Scoring 
System was developed for assessment of postural stability after concussions.
158
 Neither of these tests is 
recommended for use in other patient groups so they should not yet be administered to survivors of 
pediatric CNS tumours. 
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Some standardized outcome measures were developed for specific age brackets within 
childhood and therefore would not be applicable for use in all children and adolescents. The Ghent 
Developmental Test was created to evaluate the progression of balance abilities in children aged 18 
months to 5 years.
159
 Similarly, the Maastricht's Motor Test was created to qualitatively and 
quantitatively assess movement in 5 to 6 year olds and includes both a dynamic and static balance 
subtest.
160
 Neither of these tests can be used in children older than the suggested ages as the balance 
items would not be challenging enough for older children and adolescents. 
A few tests that were originally developed for adults have been modified for use in the 
pediatric population. The Functional Reach Test (FRT) was initially developed for use in the elderly 
and has been studied extensively in this group and found to be a reliable tool that assesses balance in a 
dynamic and functional way.
161
 Donahoe et al. (1994) were the first to propose the use of the FRT in 
the pediatric population.
162
 Subsequent studies revealed poor test-retest reliability.
163
 Owing to this low 
reliability, Bartlett and Birmingham (2003) modified the FRT to create the Pediatric Reach Test 
(PRT).
164
 They proposed using the FRT in the sitting and standing positions as well as adding a side 
reach position.
164
 Key features of the PRT as well as its psychometric properties are summarized in 
Table I (p.33). Volkman et al. (2007) also proposed modifications to the FRT in both the way that the 
reach was performed and measured.
165
 Their results demonstrated that a two-arm reach and measuring 
the distance from finger to toes was more reliable than traditional methods.
165
 No data exists on the use 
of the FRT or PRT in children and adolescents with CNS tumours. 
Another test that was modified for use in the pediatric population is the Berg Balance Test. As 
with the FRT, the Berg Balance Test was originally designed to evaluate balance abilities and risk of 
falls in an elderly population.
166
 Franjoine et al. (2003) modified this test to create the Pediatric 
Balance Scale (PBS) after examining use of the Berg in children and found that many of them had 
difficulty completing items due to their behaviour and attention span.
167
 They pilot tested the PBS, 
which re-ordered the items of the Berg and lowered the time standards for certain tasks.
167
 Table I 
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(p.33) presents psychometric properties of this tool. A follow-up study tested the PBS in 643 typically-
developing children between the ages of 2 and 13 years and found a ceiling effect in children over the 
age of 7 years old.
168
 Therefore it was recommended that the PBS be used to assess balance abilities in 
children aged 3 to 7 years old and in those with mild to moderate motor impairments.
168
 
Finally, the Pediatric Clinical Test of Sensory Interaction for Balance (PCTSIB) was created 
as a more objective and standardized version of the adult one.
169
 In this test, children are asked to 
maintain standing balance under six different sensory conditions with their feet placed in two different 
positions, feet together and tandem.
169
 Scores are obtained from the duration that the stance is 
maintained and the amount of sway. A second evaluator is necessary in order to accurately calculate 
sway, which is measured by placing a backdrop with lines denoting various angles behind the 
participant.
169
 Reliability of the PCTSIB is summarized in Table I (p.33). A study investigating the use 
of the PCTSIB in children aged 4 and 5 years old suggested using only the feet together position in this 
age group as the tandem position was too difficult and few children could maintain it.
170
 Another found 
concurrent validity to be lacking and was unable to establish construct validity of the PCTSIB with a 
slight modification in typically-developing children aged 5 through 16 years old.
171
 As validity is 
questionable and there is no consensus on which positions to use as well as the fact that two evaluators 
are required to properly administer the PCTSIB, it may not yet be a feasible tool to use to assess 
standing balance in the pediatric population. 
There also exist a number of standardized outcome measures that assess motor development or 
ability in the pediatric population that include balance items. However, only two report balance subtest 
scores separately. One is the Movement Assessment Battery for Children (mABC)
172
. This test 
underwent a recent revision but reliability and validity data for this updated version is lacking.
173
 
Furthermore, the manual accompanying the revised mABC reports information based on the original 
version.
173,174
 Certain features of the mABC and its psychometric properties are summarized in Table I 
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(p.33). It may be difficult to recommend the use of the mABC until further studies are conducted to 
investigate its psychometric properties, especially for the balance subtest as there are only 3 items. 
Another pediatric test with a separately reported balance subtest is the Bruininks-Oseretsky 
Test of Motor Proficiency – 2nd edition (BOT-2). This test is a recent revision of an earlier version and 
is a test of both fine and gross motor skills.
175
 For each subtest, including the balance subtest, point 
scores can be converted into standard scores and into descriptive categories of performance (well-
above average, above average, average, below average and well-below average).
175
 Psychometric 
properties of the BOT-2 balance subtest are summarized in Table I (p.33).The BOT-2 may be better 
suited to fully evaluate balance in the pediatric population as both static and dynamic tasks are used 
and a wide range of ages can be tested. Furthermore, the balance subtest can be independently 
administered and provide meaningful information without the need to combine the results into a total 
score. 
Overall, there are several seemingly well-developed outcome measures to test standing 
balance in the pediatric population; however, reliability and validity has not always been extensively 
investigated especially for the revised versions of some tests. Furthermore, none of the measures have 
had their psychometric properties evaluated in survivors of pediatric CNS tumours. Several of the 
existing tools could be applicable as they include normative data from large samples of children and 
adolescents. Future studies are warranted to fully validate these outcome measures for use in survivors 
of pediatric CNS tumours. 
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Table I: Summary of select pediatric balance outcome measures 
Test 
Name 
Modified 
from 
Recommended 
Age 
Number of 
Items 
Validity Reliability Normative 
Data 
Conditions 
Evaluated In 
PRT
164
 Functional 
Reach Test 
Not specified 6 items Concurrent
164
 
Construct
164
 
Intra-rater (ICC = 0.54-
0.88)
164
 
Inter-rater (ICC = 0.50-
0.93)
164
 
Not 
available 
-Cerebral 
Palsy
176
 
-Down’s 
Syndrome
177
 
PBS
167
 Berg 
Balance 
Scale 
3-7 years 14 items Not 
established 
Test-retest (ICC = 0.998)
167
 
Inter-rater (ICC = 0.997)
167
 
Not 
available 
-Mild to 
moderate motor 
impairments
167
 
PCTSIB
169
 Modified 
from adult 
version 
4-9 years 6 sensory 
conditions 
tested in two 
standing 
positions 
(feet 
together and 
tandem) 
Not 
established 
Test-retest (Spearman = 
0.51-0.88)
163
 
Inter-rater (Spearman = 0.69-
0.92)
169
 
 
Yes -Cerebral 
Palsy
163
 
-Learning 
disabilities
163
 
mABC
172
 Revised in 
2007 
3-16 years 3 items in 
balance 
subtest 
Content
172
 
 
Test-retest (Pearson = 
0.73)
173
 
Yes  
 
-Developmental 
Coordination 
Disorder
178,179
 
BOT-2
175
 Revised in 
2005 
4-21 years 9 items in 
balance 
subtest 
Not 
specifically 
evaluated for 
balance 
subtest 
Inter-rater (Pearson = 
>0.90)
180
 
Yes -Intellectual 
disabilities
178,179
 
Abbreviations used: PRT = Pediatric Reach Test, ICC = Intraclass correlation coefficient, PBS = Pediatric Balance Scale, PCTSIB = Pediatric 
Clinical Test of Sensory Interaction for Balance, mABC = Movement Assessment Battery for Children, BOT-2 = Bruininks-Oseretsky Test of 
Motor Proficiency – 2nd edition 
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2.3.4.2 Laboratory Balance Measures 
 Standing balance can also be evaluated using various biomechanical approaches that require 
more sophisticated equipment. Among those, the use of a force platform appears to be one of the more 
popular options. The majority of the literature describing these methods is focused upon the control of 
quasi-static standing balance. As previously mentioned, the force platform is used to measure the COP, 
which is thought to reflect the oscillations of the COM during quiet standing.
117
 This technique has 
been used in clinical and research settings for various pediatric patient groups including children and 
adolescents with cerebral palsy and ALL.
181-184
 However, all of the research investigating the best ways 
to analyze data obtained on a force platform has been conducted with healthy young adults or the 
elderly.  
There are many different ways in which the trajectory of the COP can be analyzed during 
standing. A lack of consensus stems from the fact that there is no normal pattern for COP movement 
and that there exists a plethora of COP variables that are inter-related and often redundant.
185
 It has 
been suggested that COP parameters be grouped into categories measuring different aspects of the 
COP trajectory and only select variables from each grouping be chosen for analysis.
185-187
 It has also 
been suggested that parameters which include both anteroposterior and mediolateral components are 
preferable.
186
 Some of the more commonly used COP parameters are the mean velocity and sway area 
as represented by the 95% confidence ellipse area.
186,188,189
 The mean velocity of the COP has been 
found to be the most reliable of all parameters and is thought to be related to the amount of regulatory 
activity associated with maintaining a quiet standing position.
185,186,189,190
 The 95% confidence ellipse 
area is defined as the area that is expected to contain 95% of the points of the COP path, which in turn 
provides information of the size of the COP oscillations.
185,186
 Results of a systematic review of the 
literature regarding COP parameters suggest that the selection of variables should include both 
distance and time-distance variables, highlighted by both the 95% confidence ellipse area and the mean 
velocity.
189
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Reliability testing for these COP parameters has been conducted almost exclusively in healthy 
adults.
189
 A systematic review by Ruhe et al. (2010) attempting to examine the reliability of various 
COP variables found that comparison of results between studies is impossible.
189
 This is due to the fact 
that the methodology, for example trial length, number of trials, positions tested and statistical methods 
for analyzing data, of each study is different.
189
 Another set of studies use the Generalizability Theory 
to assess the reliability of COP parameters in quiet standing.
188,191
 Overall, these studies found low to 
moderate reliability of the various COP parameters in young healthy adults but sample sizes were quite 
small.
188,191
 Unfortunately, little is known about the reliability of these COP parameters in general, let 
alone in the pediatric population. It thus becomes difficult to extrapolate the results of reliability 
studies to the population of pediatric CNS tumour survivors. 
Because the methodology is highly variable between studies, there is a lack of consensus as to 
the best procedures for collecting data regarding quasi-static standing balance using a force platform. 
As was the case with reliability, studies investigating this have been conducted primarily in healthy 
adults. One area where there are definite discrepancies is with regards to the length of individual trials. 
A few studies have found that different trial lengths are required to optimize reliability of individual 
COP variables.
192,193
 Studies have suggested trials from as little as 20-30 seconds up to 600 seconds.
192-
194
 The systematic review by Ruhe et al. (2010) found that reliability improved as the length of the trial 
increased and that a 90-second trial should be used as this appears to provide the best compromise 
between reliability and what is clinically feasible.
189
 However, this is based primarily on samples from 
a healthy adult population and 90-second trials are likely impractical in a pediatric setting due to their 
lower attention spans. Therefore, this suggested trial length needs to be validated in the pediatric 
population. There is also lack of consensus on the number of trials to use as protocols in individual 
studies vary. In their systematic review, Ruhe et al. (2010) suggest taking the average of 3-5 trials; 
however, there is no empirical evidence to support this.
189
 Moreover, there are many other factors that 
have been shown to shape performance on individual trials of standing balance on a force platform. 
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For example, one study demonstrated that different verbal instructions influenced outcomes.
195
 
Additional factors that have been found to affect data collection are the size of visual feedback 
provided as well as foot placement.
196,197
 It has been suggested that in order to better compare results, 
foot placement be standardized between participants.
197
 Thus there exist no optimal protocols for the 
use of a force platform to assess the control of quasi-static standing balance in any population. 
There are extremely few studies specifically investigating how to best assess dynamic aspects 
of standing balance using a force platform and they have used diverse methodological approaches. 
Some researchers utilize procedures where the force platform itself moves causing externally driven 
perturbations but this type of testing requires specially-designed and expensive force platforms.
187
 
Other methods described to evaluate the dynamic aspect of standing balance have been based on self-
initiated perturbations. For example, several studies utilize a method known as the limits of stability 
(LOS).
198,199
 These studies require the participants to trace a circle with the largest radius possible by 
leaning as far as they can while maintaining both feet in contact with the force platform.
198,199
 This may 
not be feasible in children as the concept and instructions could be difficult for them to understand. An 
additional approach to evaluating dynamic standing balance is the multi-directional reach test 
(MDRT), whereby the distance a person is able to reach in various directions is measured by a ruler. A 
study investigating the validity of the MRDT found that although it appears to measure the same 
construct of balance as the LOS, only fair correlations exist between the centre of pressure (COP) 
displacements calculated by these two methods.
200
 Using COP data to analyze MDRT may provide 
meaningful information on the strategies participants use to complete the tasks. Reaching in various 
directions while data is collected via a force platform has been used in several studies to evaluate 
sitting balance in participants with spinal cord injury.
201,202
 This technique may be useful to assess 
standing balance in children and adolescents as well as survivors of pediatric CNS tumours as 
instructions are simple for children to understand and represent a goal-oriented task. Unfortunately, 
none of the above mentioned methods have been tested for validity and reliability in children and 
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adolescents. Overall, there is no gold standard to assess quasi-static and dynamic standing balance 
using laboratory measures in the pediatric population. 
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Abstract: 
This review aims to explore the literature investigating balance outcomes in survivors of childhood 
cancer. A structured search of five databases resulted in sixteen articles included in this review. Nearly 
all were classified as Level 4 evidence using the updated Oxford Centre for Evidence-Based Medicine 
Levels of Evidence. Balance abilities have been investigated solely in survivors of acute lymphoblastic 
leukaemia or central nervous system tumours. The literature tends to support the idea that survivors 
present with balance difficulties but the results need to be closely scrutinized. Several studies report 
results using the same experimental group, while other studies use balance outcome measures that have 
not had their psychometric properties assessed with this population. There are also few studies that 
evaluate dynamic balance abilities in survivors of paediatric cancers, which may be more influential on 
functional tasks. Furthermore, very few of the included studies investigate how the found balance 
deficits affect this population’s daily lives, which would be necessary in order to determine if 
intervention should be geared towards this area. Directions for future research should also include 
multi-centred, clinically-oriented trials to evaluate balance abilities in survivors of childhood cancers 
compared to healthy control subjects in order to strengthen the literature. 
 
Keywords: cancer, children, adolescents, survivor, posture, balance 
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Introduction: 
 With progress made in the treatment of paediatric cancers, children and adolescents are 
surviving longer than before. Although incidence rates appear to be rising, so has prognosis.
65,203
 In 
Europe, 5 year survival rates for all forms of paediatric cancer are reported between 72%-83%.
65,203-205
 
These survival rates are similar to those in North America.
1,30
 As the population of survivors continues 
to grow, so too has the interest in studying the long-term outcomes in this group. There have been 
several recent systematic reviews or meta-analyses done describing the health-related quality of life, 
neurocognitive status and social functioning in survivors of childhood cancers.
4,5,206,207
 Physical 
functioning has been less extensively investigated.  
The studies that have been conducted in this area have focused on only one aspect of the 
physical domain such as writing tasks, range of motion and strength, visuomotor deficits, or gait 
analysis.
208-212
 For example, Fiorillo et al. analyzed gait in survivors of posterior fossa brain tumours 
and found that survivors demonstrated increased stance phase and wider step width than controls.
209
 
The wider step length may imply balance difficulties as the subjects may be using a wider step width 
to enlarge their base of support but balance, nor the relationship between balance abilities and gait, 
were not explicitly investigated in this particular study. 
Physiotherapists working with paediatric cancer survivors may observe that this population 
demonstrates difficulties in maintaining balance. Balance or postural stability can be defined as the 
ability to maintain one’s centre of mass within the limits of their base of support and requires the 
proper functioning and interaction of the visual, somatosensory and vestibular systems.
114
 Treatments 
received for paediatric cancers may impact one or more of these systems. For example, the use of 
certain chemotherapeutic agents, such as vincristine, have been known to cause sensory or mixed 
sensorimotor peripheral neuropathies.
213
 Long-term effects of treatments may also lead to other body 
changes in survivors; for example, children having undergone radiation therapy are at higher risk for 
obesity which has been shown to lead to decreased balance abilities when performing more complex 
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tasks.
214,215
 One could postulate that survivors of paediatric cancers may be at risk for developing 
balance deficits due to their treatment. 
A better understanding of balance abilities in survivors of paediatric cancers is important in 
order to inform professionals on the extent to which they may need to address this issue in the 
management of their patients. The primary aim of this paper is to present findings of a structured 
review of the available literature focusing on the balance outcomes of survivors of childhood cancer. 
 
Methods: 
A search of the literature was conducted using the following databases: Medline, CINAHL, 
PsycINFO, EMBASE and PEDro. The search terms entered were: ―neoplasm‖, ―psychomotor 
performance‖, ―postural balance‖ and the corresponding MESH words were used to perform individual 
queries. The resultant searches were combined as follows: ―neoplasm‖ AND ―psychomotor 
performance‖ OR ―postural balance‖. The inclusion criteria for the retrieved studies were: 1) the 
primary outcome must be of motor interest (i.e. not quality of life, cognitive outcomes, etc...), 2) 
studies with human subjects, 3) the use of standardized outcome measures to quantify balance, 4) the 
majority of subjects included were diagnosed and treated <18 years old for any form of paediatric 
cancer and 5) any type of published article or abstract found in peer reviewed journals after 1990 until 
July 2011 including case reports, retrospective studies, cross-sectional studies and abstracts or posters 
presented at conferences with published proceedings. Exclusion criteria were: 1) studies using only 
questionnaires to assess balance, 2) studies including subjects who had ongoing treatment, 3) studies in 
languages other than English or French and 4) studies that included subjects with secondary 
neurological conditions or other medical conditions that could influence postural control. 
In order to compare the results of the retained articles, certain information regarding the 
subjects and methodology was extracted and recorded. For each study, the diagnoses of the subjects as 
well as their age at diagnosis were noted. Also, the subjects’ ages at evaluation and the time post-
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treatment that the evaluation took place were extracted. If a control group was used, information such 
as what the matching criteria were, if any, was documented. Finally, it was noted exactly what balance 
outcome measures were used in each study and the primary results obtained regarding these measures. 
Additionally, the included articles/abstracts were classified into levels of evidence using the 
updated Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence.
216
 The primary 
reason for using this classification system is that it is applicable to a broader range of clinical questions 
and the organization of levels has been simplified from the original version.
217
 The row used to rate the 
retained articles was the first one that considers the question: How common is the problem? (See Table 
II (p.42)). This row offers four different levels of classification based on where the information comes 
from. 
 
 
Table II: Oxford Centre of Evidence-Based Medicine 2011 Levels of Evidence – Question: How 
common is the problem?
216
  
 
Level 1 Local and current random sample surveys (or 
censuses) 
Level 2 Systematic reviews of surveys that allow 
matching to local circumstances 
Level 3 Local non-random sample 
Level 4 Case-Series 
Level 5 Not Applicable 
 
Results: 
 After searching all five databases, a total of 1924 articles were retrieved. After duplicate 
results were removed and titles and abstracts scanned, 88 articles were read in their entirety. The 
reference lists of read articles were scanned leading to another 41 abstracts consulted and 13 more 
articles read. Overall, 101 articles were verified for fulfilment of inclusion and exclusion criteria. A 
total of 16 articles were included in this review. Articles were excluded for reasons presented in the 
flow chart in Figure 1 (p.43).  
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Figure 1: Flow chart for retrieved articles including reasons for exclusion 
 
 
 
 
 
Relevant Articles n = 
1924
Excluded on basis of 
title and abstract n = 
1823
Articles verified for 
inclusion and 
exclusion criteria n = 
101
Reasons for exclusion:
- Balance not assessed n = 65
- Balance subtests not reported separately 
from total score in outcome measures n = 8
- Balance assessed subjectively n = 3
- Subjects with associated conditions that 
could influence control of balance n = 3
- Majority of subjects were >18 years of age 
at time of diagnosis n = 6
Included publications n = 16
44 
 
 The majority of the articles retained for this review had subjects that were diagnosed with 
either acute lymphoblastic leukaemia or central nervous system tumours and could be classified as 
Level 4 evidence based on the OCEBM 2011 Levels of Evidence. Information extracted from each 
article is summarized in Table III (p.45). 
 
Discussion: 
The primary aim of this paper is to present findings of a structured review of the available 
literature focusing on the balance outcomes of survivors of childhood cancer. Of the sixteen articles 
included, five focus on survivors of acute lymphoblastic leukaemia (ALL) while the remaining eleven 
focus on central nervous system (CNS) tumours. This is not surprising as ALL and CNS tumours 
represent the most common forms of paediatric cancer.
65,205
  
If one is to examine the quality of evidence regarding studies investigating balance abilities in 
survivors of paediatric cancers, according the OCEBM Levels of Evidence 2011, most included studies 
would be classified as Level 4 evidence.
216
 In fact, two articles would not be classifiable as they are 
case reports. Higher quality studies would be necessary in order to ascertain balance abilities in 
survivors of paediatric cancers. According to the OCEBM, higher levels of evidence require local 
random surveys or systematic reviews that allow for comparison be conducted.
216
 This may prove 
difficult to achieve as the population of paediatric cancer survivors although growing remains a limited 
one, as represented by the small sample sizes in each of the included studies, which range from 5-99 
subjects in the experimental groups. To achieve more comprehensive results, multi-centred studies 
would likely be necessary in the future. 
The included studies demonstrate that many survivors of childhood cancers present with 
balance difficulties; however, these results need to be more profoundly dissected. If we first look at the 
studies investigating balance in survivors of ALL, all studies include subjects that are at least one year 
post-treatment. Four of the five studies are conducted by the same group of researchers where the  
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Table III: Data extraction table for retained articles 
 
Article Level of 
Evidence 
Diagnosis 
+ number 
of subjects 
Age at 
Diagnosis 
Age at 
Evaluation 
Time 
post- 
treatment 
at 
evaluation 
Control 
Group 
Balance Outcome 
Measure(s) used 
Primary Results 
Wright et 
al., 1996
218
 
Level 4 ALL n=36 
Wilms’ 
Tumour 
n=9 
Not 
specified 
Not 
specified 
Not 
specified 
Yes n=36 
comparable 
healthy 
children 
BOTMP Balance 
Subtest 
-Balance scores worse 
in ALL than other 
groups (p<0.001) 
-No difference 
between controls and 
Wilms’ tumour group 
Wright et 
al., 1998
219
 
Level 4 ALL n=36 0.3-8.8 
years 
5.5-14.5 
years 
 
>12 
months 
Yes n=36 
healthy 
children 
matched 
for age and 
gender 
BOTMP Balance 
Subtest 
-Balance scores worse 
in ALL group 
(p<0.001) 
Bastian et 
al., 1998
131
 
Level 4 Brain 
tumour: 
4
th
 ventricle 
tumour n=5 
> 4 years 
old 
6-15 years 1-24 
months 
Yes n=5 
healthy 
children 
matched 
for age, 
gender, and 
handedness 
Tandem gait 
Hopping on one leg 
(kinematic analysis of 
tasks) 
-Tandem gait: 
subjects took fewer 
steps (p≤0.01) than 
controls 
-Hopping: subjects 
showed more 
variation in height (no 
statistical information) 
than controls 
Galea et 
al., 2004
182
 
Level 4 -ALL n=79 0.3-17 
years 
5.7-25.2 
years 
>1 year Yes n=83 
healthy 
children 
matched 
for age 
Force platform: COP 
displacements, 
velocity, RMS of 
excursion 
(6 conditions tested: 
normal surface eyes 
open + eyes closed, 
-No statistically 
significant differences 
between controls and 
subjects except: 
1) youngest group of 
subjects lower 
displacement and 
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Romberg eyes open + 
eyes closed, foam 
surface eyes open + 
eyes closed) 
velocity of COP 
2) 32% of subjects vs. 
2% of controls could 
not perform Romberg 
eyes closed task 
(p<0.01) 
 
Wright et 
al., 2005
220
 
Level 4 ALL n=99 0.3-17 
years 
5.1-25.2 
years 
1.0-13.6 
years 
Yes n=89 
healthy 
children 
matched 
for age and 
gender 
BOTMP Balance 
Subtest 
-Balance scores worse 
in ALL group 
(p<0.001) 
-Cranial irradiation, 
overweight and longer 
time off treatment 
were predictors of 
poorer balance (but 
explained only 18.7% 
of variability) 
Konczak et 
al., 2005
10
 
Level 4 Brain 
Tumour: 
cerebellar 
tumour 
n=22 
1-17 
years 
10-28 
years 
>3 years 
post-
surgery 
Yes n=14 
healthy 
controls 
Force platform: total 
sway area of COG, 
length of sway path, 
(6 conditions tested: 
stable platform with 
eyes open + closed + 
sway-referenced, 
sway-referenced 
platform with eyes 
open + closed + 
sway-referenced) 
-64% of subjects had 
enlarged sway areas 
and sway path lengths 
that exceeded control 
group in conditions 
with sway-referenced 
platform and altered 
visual input  
Toy et al., 
2006
221
 
N/C Medullo-
blastoma 
and 
posterior 
fossa 
syndrome 
(case 
Not 
specified 
12 years 19 months 
post-
surgery 
No PBS 
BOTMP Balance 
Subtest 
 
Outcomes assessed at 
1,4 and 8 weeks post 
physical therapy 
Initial PBS 
score=50/56 – final 
score 54/56 
Initial BOTMP 
Balance scale score=5 
– final scale score=9 
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report, n=1) intervention 
Van 
Brussel et 
al., 2006
222
 
Level 4 -ALL n=13 
(including 1 
with non-
Hodgkin 
lymphoma) 
Not 
specified 
8.6-23.7 
years 
46-73 
months 
No Movement ABC -Reported Static and 
Dynamic Balance 
Subset: only 1 subject 
scored between 5-15
th
 
percentile (indicating 
risk for motor delay), 
the rest scored >15
th
 
percentile 
Schoch et 
al., 2006
12
 
Level 4 Brain 
Tumour: 
Cerebellar 
Tumour 
n=22 
(post-hoc 
analysis of 
previous 
study) 
1-17 
years (age 
at 
surgery) 
10-28 
years 
3-25 years 
(based on 
data in 
table) 
Yes n=14 
healthy 
controls 
Force platform: total 
sway area of COG (6 
conditions tested: 
stable platform with 
eyes open + closed + 
sway-referenced, 
sway-referenced 
platform with eyes 
open + closed + 
sway-referenced) 
-64% of subjects had 
enlarged sway areas 
and sway path lengths 
that exceeded control 
group in conditions 
with sway-referenced 
platform and altered 
visual input 
-Damage to cerebellar 
nuclei has greater 
impact on balance 
function than adjuvant 
treatment  
Syczewska 
et al., 
2006
14
 
Level 4 CNS 
tumours 
n=41 
Not 
specified 
6-17 years Not 
specified 
No Force platform: 
maximum medio-
lateral and antero-
posterior 
displacements, mean 
radius of sway and 
total path covered by 
COP (2 conditions 
tested: standing eyes 
open + eyes closed) 
-20 subjects’ balance 
did not differ from 
healthy subjects 
-21 subjects had 
balance deficits (no 
definition provided), 
75% had increased 
total COP path only 
-No statistical 
information 
Rorke-
Adams and 
Portnoy, 
N/C gliomatosis 
cerebelli 
(case 
13 
months 
18 years 
old 
17 years No Romberg test -Positive Romberg on 
left monopedal stance 
with eyes closed 
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2008
223
 report, n=1) 
Ilg et al., 
2008
132
 
Level 4 Brain 
Tumour: 
Cerebellar 
Tumour 
n=12 
Not 
specified 
13-39 
years  
10-133 
months 
post-
surgery 
Yes n=12 
healthy 
children 
matched 
for age 
-Kinematic analysis: 
step width and lateral 
body sway during gait 
-6 subjects classified 
with impaired 
balance: cut off 
criteria defined by 
control group results 
-Lesion of medial 
zone of cerebellum 
more common in 
impaired balance 
group  
Syczewska 
et al., 
2008
13
 
Level 4 CNS 
tumours 
n=88 
1-19 
years 
5-24 years 1-23 years No Force platform: COP 
sway parameters: max 
radius of sway, mean 
radius of sway, total 
sway path, max left + 
right displacements, 
max fore + aft 
displacements (2 
conditions tested: 
standing eyes open + 
eyes closed) 
Subjects were also 
scored on a scale 
created by authors 
based on COP 
variables to compare 
to reference values 
for healthy subjects 
-No statistical 
difference in any COP 
variables in either 
condition between 
groups based on 
location of tumour  
-Using the scoring 
system developed by 
the authors, only in 
the eyes open 
condition was there a 
significant difference 
between subjects and 
reference values, but 
only in group of 
subjects with tumours 
located in the 
posterior fossa 
Yissar et 
al., 2010
224
 
Level 4 Brain 
Tumour: 
Posterior 
Fossa 
Tumour 
n=13 
Not 
specified 
Mean age 
= 10.47 
>3 months No BOT-2 Balance 
Subtest 
-Balance scores 
significantly lower in 
children after 
posterior fossa tumour 
removal (no statistical 
information) 
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Moderate-
Severe 
brain injury 
n=11 
Ness et al., 
2010
88
 
Level 4 Brain 
Tumour 
n=78 
<21 years 18.4-58.3 
years 
>5 years 
post-
diagnosis 
Yes n=78 
matched 
for age, 
gender and 
zip code 
Berg Balance Test -Significantly lower 
balance scores in 
subjects (p<0.001) 
-Radiation to the 
posterior fossa or 
occipital/parietal lobe, 
treatment with 
platinum or 
vincristine and age <5 
years at diagnosis 
associated with lower 
balance scores 
(explained 26% of the 
variance) 
Schoch et 
al., 2010
11
 
Level 4 Brain 
Tumour: 
Cerebellar 
Tumour 
n=16 
3.2-38.3 
years (age 
at 
surgery) 
11.3-39.1 
years 
9.9-133.4 
months 
post-
surgery 
Yes n=16 
healthy 
controls 
Kinematic analysis: 
total body sway, 
shoulder sway, 
sagittal trunk angle 
(10 conditions tested: 
sitting eyes open + 
closed, sitting on 
cushion eyes open + 
closed, standing eyes 
open + closed, 
standing on cushion 
eyes open + closed, 
tandem standing eyes 
open + closed)   
1)Sitting: 
-On cushion eyes 
closed, 50% subjects 
demonstrated 
abnormal shoulder 
sway 
-With eyes closed, 
31.3% of subjects had 
higher shoulder sway 
-on cushion eyes 
open, 18.8% subjects 
had abnormal 
shoulder sway 
-Mean trunk angle and 
mean trunk angular 
velocity showed little 
differences between 
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groups 
2)Standing: 
-On cushion with eyes 
closed, 68.8% 
subjects values above 
normal (shoulder 
sway and lumbar 
sway) 
-Tandem with eyes 
open, 75.5% subjects 
had higher shoulder 
and lumbar sway 
values 
-Tandem with eyes 
closed,  62.5% had 
higher shoulder and 
lumbar sway values 
-Mean trunk angle 
showed little 
difference between 
the groups 
-Mean trunk angular 
velocity was higher in 
subjects 
 
Abbreviations used: ALL = acute lymphoblastic leukaemia, BOTMP = Bruininks-Oseretsky Test of Motor Proficiency 1
st
 ed., COP = centre of 
pressure, RMS = root mean square, COG = centre of gravity, N/C = Not classifiable, PBS = Pediatric Balance Scale, CNS = central nervous 
system, BOT-2 = Bruininks-Oseretsky Test of Motor Proficiency 2
nd
 ed. 
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sample population and the control groups are recruited from the same hospital setting/area and could 
potentially include the same subjects.
182,218-220
 So although there appears to be literature investigating 
balance in survivors of childhood ALL, it may not be as extensive as it initially seems. Three of their 
studies use a clinical measure of gross motor function that includes a balance subtest – the Bruininks-
Oseretsky Test of Motor Proficiency (BOTMP) and all found significantly lower scores in survivors of 
ALL compared to the control group.
218-220
 However, in a subsequent study where they used a force 
platform to measure centre of pressure (COP) displacements in static standing under various conditions 
(eyes open, eyes closed, Romberg, on foam, etc...), no statistically significant differences were found 
between groups other than the fact that more ALL survivors could not perform a Romberg test with 
eyes closed.
182
 If some of their study subjects do overlap, a given subject may be classified as having a 
balance deficit on one study using the BOTMP but their balance has been scored as normal when 
assessed by the force platform. Therefore, caution must be used when drawing conclusions from these 
studies. Similarly, the other study investigating balance in ALL survivors concluded that survivors of 
ALL do not present with balance difficulties. In this study, the Movement Assessment Battery for 
Children (Movement ABC test), a screening tool of motor performance that includes a balance subset, 
was used.
222
 Only one of thirteen subjects scored in the range that would place him/her at risk of 
difficulties. Again, we must be cautious in interpreting these results as there was no control group and 
the median age of their subjects was 15.5 years old while this clinical test was designed for use in 
children between the ages of 4-12 years old. From the results of these five studies, we may not have 
conclusive answers into the balance abilities of survivors of childhood ALL. 
Similarly, although the literature tends to support the idea that survivors of paediatric CNS 
tumours present with balance difficulties, the results of these studies need to be more closely 
scrutinized. It is interesting to note that eight of the eleven studies investigate only tumours that could 
be classified as posterior fossa tumours (i.e. located in the cerebellum and 4
th
 ventricle areas). If we 
first examine the articles that have used more clinically-based outcome measures we note that two of 
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them are case reports, which according to the OCEBM levels of evidence are not classifiable.
216
 One 
report focuses on the long-term survival of an infant with a cerebellar tumour and found that at the age 
of 18 years old, the subject demonstrated what the authors call a positive Romberg in left single leg 
stance with eyes closed, which could indicate some extent of balance difficulties.
223
 The other case 
report focuses on a 12 year old boy with a medulloblastoma who underwent physiotherapy 
intervention for balance issues approximately 19 months post-surgical intervention.
221
 The selected 
outcome measure was the BOTMP and showed that even post physiotherapy intervention, the subject’s 
score was in the range that suggests persistent balance difficulties.  
Similarly, the three remaining studies that utilize more clinically-based outcome measures, all 
demonstrate that survivors of CNS tumours present with balance difficulties.
88,131,224
 Bastian et al. 
investigated five children with prior surgical intervention for posterior fossa brain tumours using 
tandem gait and found that subjects took significantly fewer steps than controls.
131
 Likewise, Yissar et 
al. found that children having undergone resection of posterior fossa brain tumours had significantly 
impaired balance compared to published norms of the balance subtest of the second edition of the 
Bruininks-Oseretsky Test of Motor Proficiency (BOT-2) and compared to a group of children who had 
sustained moderate to severe traumatic brain injury.
224
 But, as this was published in the proceedings of 
a conference, there is neither statistical information provided nor data regarding individual subjects. 
The final study utilizing clinically-based outcome measures is a large cohort study done by Ness et al 
in 2010. Using the Berg Balance Scale, they found that survivors of childhood brain tumours at least 
five years post-diagnosis presented with significantly lower scores compared to controls, indicating a 
balance deficit.
88
  
Overall it would seem that studies and case reports using more clinically based outcome 
measures have shown that survivors of paediatric CNS tumours exhibit balance difficulties; however, 
one major consideration when interpreting these results is that none of the outcome measures used: 
BOTMP, BOT-2, tandem gait, Berg Balance Scale and Romberg test, have had their psychometric 
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properties specifically investigated in the population of children and adolescents with CNS tumours or 
any other form of childhood cancer. This may be overcome with certain tools such as the BOTMP and 
the most recent version, the BOT-2. Both are norm-referenced tools, with normative values based on a 
large sample of healthy children and adolescents.
180
 Nonetheless, as the population of survivors of 
paediatric cancers continues to grow, it will become essential to ascertain whether the available 
outcome measures that assess balance are valid and reliable for use in this population in order to better 
evaluate long-term outcomes. 
Contrarily to the clinical-based outcome measures, many of the studies using more laboratory-
based outcome measures (i.e. force platform and/or kinematic analysis) show mixed results. It also 
becomes difficult to directly compare the results from the various studies as subject inclusion criteria 
differ as well as the parameters measured and testing positions. One set of studies conducted by 
Syczewska et al. utilize a force platform to record the COP in two conditions: bipodal standing with 
eyes open and eyes closed.
13,14
 There are no control groups used; however, the subjects’ values are 
compared to those obtained with healthy children in a previous study by the lead author.
154
 In the 
preliminary report they conclude that twenty-one (of forty-one) subjects show a balance deficit and all 
of those subjects show an increase in total COP path.
14
 There is no clear definition of what constitutes 
a balance deficit. In the follow-up study, the authors further divided subjects into groups based on 
tumour location and they also developed their own 4-point (0-3) balance scoring system based on the 
results from the COP sway data.
13
 The only statistically significant result was that subjects with 
posterior fossa brain tumours had worse scores on the author-created balance scoring system in the 
eyes closed position only. It becomes problematic to draw conclusions into the balance abilities of 
survivors of childhood CNS tumours from only these two studies as the testing positions were 
extremely limited and there were no control subjects. 
In another set of three studies done by a different group of researchers, we may be able to gain 
better insight. Two of the articles report data on the exact same group of subjects – the later study a 
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post-hoc analysis on previous results obtained.
10,12
 So, as was the case with survivors of ALL, there 
may less literature than there initially appears when reviewing balance abilities in survivors of CNS 
tumours. These two articles report that 64% of their twenty-two cerebellar brain tumour subjects at 
least three years post-surgery have enlarged centre of gravity sway areas and sway path lengths when 
compared to a group of fourteen healthy controls in conditions where their proprioceptive and/or visual 
input was altered.
10,12
 This is a similar finding to the above mentioned study by Syczewska et al. where 
they reported an increased total COP path in their subjects.
14
 A later study, and the only one included 
in this review to assess sitting balance, aimed to kinematically analyze sitting and standing balance in 
sixteen subjects with benign cerebellar tumours compared to sixteen healthy controls.
11
 The tasks that 
were analyzed were ones that could easily be performed in a clinical setting with minimal equipment. 
They found that 56% of subjects in sitting and 87.5% of subjects in standing displayed abnormal 
performance, characterized by shoulder sway above the normal range or by falls, as compared to their 
control group. This group of researchers was also particularly interested in where surgical lesions were 
present in the cerebellum and how that would explain balance difficulties. Overall it would seem that 
their research supports the notion that children and adolescents treated for cerebellar tumours present 
with persistent balance deficits. 
A final study utilizing laboratory measures conducted by Ilg et al. focuses primarily on gait 
control in twelve subjects with benign cerebellar brain tumours.
132
 This was the only study utilizing 
laboratory measures that evaluated balance during a more functional and dynamic task. Using 
kinematic analysis and based on the parameters of step width and lateral sway, half of the subjects 
were classified into the impaired balance during gait group.
132
 These parameters were classified as 
abnormal based on the data obtained from the control group. In the future, more research should focus 
on the evaluation of dynamic balance abilities in this population as this may give us more information 
on their functional capabilities. 
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One interesting point from this review is the fact that there seems to be little correlation 
between treatment type (surgery, chemotherapy, radiotherapy) and balance abilities. This becomes 
more of an issue with CNS tumour subjects, compared to ALL subjects, as treatment can be either 
surgery alone or combined therapy. It is difficult to directly compare studies as inclusion criteria 
regarding treatments are variable; however, most results demonstrate some degree of balance 
difficulties regardless of whether they include subjects with only benign tumours or only malignant 
tumours. There are two studies that directly address this question and both deal with survivors of CNS 
tumours. One study, the post-hoc analysis by Schoch et al, concludes that the area of the cerebellum 
that is lesioned during surgery has more of an impact on balance deficits than adjuvant therapy for 
cerebellar tumours.
12
 On the other hand, the other study found an association between lower balance 
scores and radiation treatment and treatment with platinum or vincristine, although these variables 
along with tumour location and age of less than five years old at diagnosis explained only 26% of the 
variance on the Berg Balance Scale.
88
  
Overall it does seem that balance appears to be impaired to some extent in survivors of 
paediatric cancer but one important concept that is not addressed is if and how these deficits interfere 
with this population’s daily life. Of the articles retained for this review, only one attempted to gain 
some insight into this question. In one of their studies, Wright et al. used the Child’s Self-perceptions 
of Adequacy in and Predilection for Physical Activity Scale (CSAPPA) and the Health Utilities Index 
(HUI) in their study with children who had been treated for ALL.
220
 They found that there was no 
statistically significant relationship between CSAPPA scores and balance scores (from the BOTMP) 
but did find that balance scores associated positively with HUI scores.
220
  
Strengths of this review article include a 20 year time frame for the search, making certain that 
articles are relevant to the current population of survivors (i.e. keeping with modern medical 
management of paediatric cancers). Similarly, broad inclusion and exclusion criteria ensured that any 
potentially relevant articles were not overlooked. Finally, the extracted data regarding the outcome 
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measures from the retained articles was extremely detailed thereby making it easier to compare the 
various studies. One major limitation of this review article was the quality of the studies included. 
Most studies were classified Level 4, the lowest level, while two were not classifiable according to the 
Oxford Centre of Evidence-Based Medicine 2011 Levels of Evidence. This highlights that further 
studies are necessary in order to get a clear idea of balance abilities in the population of paediatric 
cancer survivors. 
 
Conclusion:  
The aim of this paper was to review the available literature on balance outcomes in survivors 
of paediatric cancers. Although at first glance it may seem that there is extensive literature in this area, 
several of the studies have overlapping subjects and discuss results from the same experimental group. 
All the articles discuss survivors of either acute lymphoblastic leukaemia or central nervous system 
tumours, which is unsurprising as these are the most common forms of paediatric cancer. Overall, the 
few studies available seem to suggest that balance abilities in survivors are decreased when compared 
to healthy controls; however, not all studies included control groups. The quality of the studies 
supporting this conclusion is of a low level and this may only be overcome by collaborative, multi-
centred studies in the future. Some of the studies are more clinically-oriented than others but few 
explicitly investigate dynamic balance tasks. Future studies should evaluate dynamic balance abilities 
in survivors of paediatric cancer as this may be more related to functional tasks. Furthermore, studies 
should focus on investigating the relationship between balance abilities and quality of life as it would 
guide health care professionals on whether or not balance would be an important area to focus their 
interventions on. 
 
 
Chapter 4: Objectives and Hypothesis 
4.1 Objectives 
 The general objective of this study is to describe balance abilities in survivors of pediatric 
posterior fossa brain tumour (PFBT) using a variety of methods.  
The specific objectives are: 
1) To quantify quasi-static and dynamic standing balance in survivors of pediatric PFBT 
using clinical outcome measures (the balance subtest of the Bruininks-Oseretsky Test of 
Motor Proficiency, 2
nd
 edition and the Pediatric Balance Scale) and laboratory measures 
and to compare their performance to that of matched healthy children and adolescents:  
2) To evaluate quality of life in survivors of pediatric PFBT and to compare their results to 
the matched control group: 
3) To determine the association between standing balance and quality of life in children and 
adolescent survivors of PFBT. 
 
4.2 Hypotheses: 
 The hypotheses of this research study were that:  
1) PFBT survivors will show decreased balance capabilities when compared to healthy 
controls. 
2) Quality of life will be lower in survivors of pediatric PFBT as compared to controls. 
3) Better quasi-static and dynamic balance abilities will be associated with improved quality 
of life in survivors of pediatric PFBT. 
 
Chapter 5: Methodology 
 The following section will elaborate on the methods used for this research study. First, the 
process for obtaining approval from the ethics committee is described. Then, the procedures for 
participant recruitment with the inclusion and exclusion criteria are explained. This is followed by an 
explanation of the various aspects of the data collection: the clinical evaluation, the clinical balance 
assessment and the HRQOL evaluation. Finally methods regarding statistical analysis and sample size 
justification will be provided. 
 
5.1 Ethics Approval 
 Ethical approval was obtained from the Research and Ethics Committee of the Montreal 
Children's Hospital of the McGill University Health Centre (Appendix A). Informed consent was 
obtained for all participants and their parents, for those under the age of 18 years old, and informed 
consent and assent forms were signed prior to participation in this study (Appendix B). 
 
5.2 Study Design 
 This is an analytical cross-sectional study comparing standing balance between survivors of 
pediatric posterior fossa brain tumour (PFBT) and healthy children and adolescents. 
 
5.3 Participant Recruitment 
 The experimental group, consisting of survivors of pediatric PFBT were recruited from the 
neuro-oncology clinic of the Montreal Children’s Hospital of the McGill University Health Centre. A 
control group of age- and gender-matched healthy children and adolescents was also recruited via 
publicity placed throughout the hospital and word of mouth. 
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5.3.1 Inclusion and Exclusion Criteria 
 The following inclusion and exclusion criteria were used when recruiting participants for this 
study. 
 Inclusion criteria for experimental group:  
 Having received the diagnosis of PFBT at the age of 4 years or older 
 To be at least 6 months post-completion of treatment for the brain tumour (either 
neurosurgical intervention, radiotherapy and/or chemotherapy) 
 To be English or French speaking  
 To possess the ability to maintain a standing position independently without the use of 
an assistive device for at least one minute 
 The inclusion criteria for the control group were as per the experimental group except for the 
diagnosis and treatment of brain tumours. 
 
Exclusion criteria for all participants were as follows: 
 Other pre-existing musculoskeletal or neurological diagnoses that would affect 
standing balance. 
 Any visual field deficits that have been diagnosed by an ophthalmologist. 
 Severe cognitive impairments that would make them unable to follow simple 
directions or to concentrate on a task. 
 
5.4 Data Collection Procedures 
The following section will outline all aspects of the data collection procedures for the 
participants with the exception of the dynamic balance assessment using the laboratory procedures. 
This will be outlined in the second manuscript, which directly follows the methodology chapter. 
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5.4.1 Clinical Evaluation 
 Testing was done in a quiet room by an experienced pediatric physiotherapist. Participant’s 
height and weight was measured. Lower extremity range of motion (ROM) (hip flexion, knee 
flexion/extension, ankle dorsiflexion/plantarflexion) was assessed using an Accumar Inclinometer
*
 
while strength of key lower extremity muscle groups (hip extensors, hip abductors, knee extensors, 
ankle dorsiflexors) was tested using a hand-held dynamometer
†
. The procedure for dynamometry used 
was the one described by van den Beld et al. (2006), which showed high test-retest reliability in 
children.
225
 Ankle plantarflexor strength was assessed using standing single leg heel raises as it cannot 
be accurately measured with a hand-held dynamometer.
226
 Sensation was assessed in two ways: light 
touch and proprioception. Although the psychometric properties of the monofilaments are disputed, 
light touch was measured in the foot and ankle using select monofilaments
‡
 with the following 
delineations: 2.83(0.07g) normal, 3.61(0.4g) normal, 4.31(2.0g) diminished light touch, 4.56(4.0g) 
diminished protective sensation, 5.07(10g) loss of protective sensation, 6.65(300g) deep pressure 
sensation only. Proprioception was assessed, as described by Thibault et al. (1994), by passively 
moving the subject’s ankle while they were blinded and asking them to identify the position. This 
method has demonstrated excellent test-retest reliability in children.
227
 
 
5.4.2 Clinical Balance Assessment 
 Clinical measures of quasi-static and dynamic standing balance were done with a rest given in 
between tests. The two tools that were used were the balance subtest of the BOT-2 and the PBS. Both 
of these tools were described in the literature review chapter. The order of the tools was reversed for 
half the subjects. These two tools were chosen as they are the most widely used by physiotherapists to 
assess balance in the pediatric population. 
                                                          
*
 Accumar single digital inclinometer, Lafayette Instrument Company, Lafayette, Indiana. 
†
 MicroFET2 Muscle Tester, Hoggan Scientific LLC, Salt Lake City, Utah. 
‡
 Touch-Test Sensory Evaluators – Foot Screening Kit, North Coast Medical Inc, Gilroy, California 
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5.4.3 Health-Related Quality of Life Evaluation 
 The Pediatric Quality of Life Inventory (PedsQL4.0) Generic Core Scales is a patient or parent-
reported HRQOL measure for use in all children.
228
 There exists multiple versions for various age groups; 
young child 5-7 years old, child 8-12 years old and teen 13-18 years old. Separate parental proxy versions are 
also available for each age group. The questionnaire incorporates 23 items in areas such as physical, 
emotional, social and school functioning. Each item is scored on a 5-point Likert scale from 0-4 except for the 
young child version, which is scored on a 3-point scale. Total point scores can then be converted to a scale 
ranging from 0-100. All versions are available in both English and French. Psychometric analysis has revealed 
construct validity and internal consistency in both healthy children and children with brain tumours.
228-230
 
 
5.5 Statistical Analysis 
Data for all variables and outcome measures were summarized and descriptive statistics were 
compiled for both the experimental and control groups. In order to compare standing balance abilities 
on all the clinical measures and to compare HRQOL between the two groups, Mann-Whitney U tests 
were used. Due to the non-parametric nature of the test scores, a Spearman’s rank correlation 
coefficient (ρ) was used to determine the association between balance abilities and HRQOL for the 
experimental group. The level of statistical significance was set at an alpha of 0.05 and all data was 
analyzed using SPSS® statistical analysis software. 
 
5.6 Sample Size Justification 
As there had been no prior studies using the primary outcome measure in survivors of PFBT, 
calculations were based on two prior studies done in pediatric survivors of ALL.
219,220
 This was 
deemed a comparable population as chemotherapy agents used in the treatment of leukemia patients 
are also used in brain tumour patients. In these studies an effect size of 6 and standard deviation of 5 
were found using the BOT-2 balance subtest (our primary outcome measure).  If a similar effect size 
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was to be found in our study, sample size was fixed at 20 subjects per group, with a power greater than 
80%. Unfortunately, due to slow recruitment, this number has not yet been reached for the 
experimental group. 
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Abstract: 
BACKGROUND: The most frequent location of childhood brain tumours is the posterior fossa, which 
includes the cerebellum that plays a crucial role in balance. Few studies assess standing balance in this 
population. Standing balance difficulties may interfere with motor functions, in turn affecting health-
related quality of life (HRQOL). OBJECTIVES: To compare standing balance and HRQOL between 
survivors of childhood posterior fossa brain tumours and a control group and to explore any 
associations between balance and HRQOL. METHODS: 6 males aged 7-18 years having completed 
treatment for a posterior fossa brain tumour and six healthy controls were recruited. Balance was 
assessed using the Bruininks-Oseretsky Test of Motor Proficiency–2nd ed. (BOT-2) and the Pediatric 
Balance Scale (PBS). HRQOL was measured using the Pediatric Quality of Life Inventory 
(PedsQL4.0). RESULTS: BOT-2 scores were significantly lower (p=0.004) in survivors (mean=9.5) 
versus controls (mean=15.67). The PBS demonstrated a ceiling effect and HRQOL was similar in both 
groups. In survivors, an association (ρ=0.715) was found between the BOT-2 and physical dimension 
of the PedsQL4.0. CONCLUSIONS:  Survivors of childhood posterior fossa brain tumours 
demonstrate significant balance deficits after ending treatment; however, they report relatively normal 
HRQOL. In survivors, better balance abilities may contribute to better HRQOL. 
 
Key Words: postural control, health-related quality of life, brain tumour, pediatrics, survivor 
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Introduction: 
As survival continues to improve after the diagnosis of childhood brain tumours, there is a 
growing interest in studying the long-term outcomes in this population. Late-effects may be due to the 
tumours themselves or to the effects of treatment on the developing brain. Although a large amount of 
literature is available for certain areas like cognitive and social outcomes, there are fewer studies that 
explore the late-effects of treatment on physical and functional outcomes.
4,5
 Many of the available 
studies report physical and functional deficits based on physician assessment or via subjective 
questionnaires.
3,80
 In fact, very few studies use standardized, objective outcome measures to assess 
physical functioning in survivors of childhood brain tumours. 
The most frequent location of childhood brain tumours is the posterior fossa, a region of the 
brain that includes the cerebellum and brainstem.
7
 The cerebellum is known to play a crucial role in 
the control of balance.
9
 One can expect that a brain tumour, especially one located within the posterior 
fossa, could have deleterious consequences on postural and motor control. Therefore, it is surprising 
that there is not more research conducted into the physical outcomes, including postural control and 
balance in standing, of survivors of childhood brain tumours. 
On the other hand, there is a growing body of literature on health-related quality of life 
(HRQOL) in survivors of childhood brain tumours. Some studies report significantly lower HRQOL 
while others demonstrate that survivors of brain tumours rate their HRQOL similar to published 
norms.
106,231
 It can be postulated that difficulty in maintaining standing balance may lead to difficulty 
performing certain motor tasks or functions that could in turn affect quality of life. It would be 
interesting to verify if there exists a relationship between balance abilities and HRQOL since quality of 
life may not be routinely measured in the clinical setting for survivors of childhood brain tumours. 
The primary objective of this exploratory study was to describe standing balance abilities in 
survivors of childhood posterior fossa brain tumours and to compare their results to those of age- and 
gender-matched controls. Secondary objectives were to compare HRQOL between survivors of 
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childhood posterior fossa brain tumours and controls and to explore any associations between balance 
scores and HRQOL in the experimental group.  
 
Methods: 
Subjects 
A group of 6 males aged between 7-18 years old were recruited from the neuro-oncology 
clinic of the Montreal Children’s Hospital of the McGill University Health Centre. Individual 
characteristics regarding age at diagnosis, tumour pathology and adjuvant treatment received are 
summarized in IV (p.69). Inclusion criteria were: 1) the diagnosis of posterior fossa brain tumour at ≥ 
4 years of age; 2) to be ≥ 6 months post-completion of treatment; and 3) to have the ability to maintain 
a standing position independently, without the use of an assistive device, for one minute. Participants 
were excluded if they had any other conditions that could affect their balance (i.e. visual field deficits) 
or their ability to follow directions. A convenience sample of volunteers recruited through publicity 
placed in the hospital and through word of mouth formed a control group of age- and gender-matched 
healthy children or adolescents. Informed consent was obtained from all participants and their parents 
and ethical approval was granted from the Research and Ethics Committee of the Montreal Children's 
Hospital. 
 
Data Collection 
 Testing was done in a quiet room by an experienced pediatric physiotherapist. Two clinical 
balance tests were administered, as described below, and the order of the tests was reversed for half the 
participants. Finally, the HRQOL questionnaire was administered to the participants and their parents 
separately. The testing session lasted approximately 30 minutes. 
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Outcome Measures 
Bruininks-Oseretsky Test of Motor Proficiency – 2nd edition (BOT-2) 
 The BOT-2 is a test of both fine and gross motor skills developed for children, adolescents and 
young adults between the ages of 4-21 years old.
175
 The balance subtest comprises 9 tasks that assess 
both static and dynamic standing balance and point scores can be converted into standard scores. 
Standard scores can be divided into the following descriptive categories (based on the standard 
deviation (SD) from the mean standard score of 15): well-below average 0-5, below average 6-10, 
average 11-19, above average 20-24, well-above average ≥25.175 Good inter-rater and test-retest 
reliability have been found as well as adequate content and construct validities.
180
 
 
Pediatric Balance Scale (PBS) 
 The PBS is comprised of 14 items that assess both quasi-static and dynamic balance and is a 
modified version of the Berg Balance Scale.
167
 The PBS re-orders the items of the Berg and lowers the 
time standards for certain tasks. Extremely high test-retest reliability has been reported as well as high 
test-retest and inter-rater reliability in children with mild to moderate motor impairments.
167
 
 
Pediatric Quality of Life Inventory (PedsQL4.0) Generic Core Scales 
The PedsQL4.0 is a self and/or parent-reported HRQOL measure for use in all children.
228
 There 
exists multiple versions for various age groups; young child 5-7 years old, child 8-12 years old and teen 13-18 
years old. The questionnaire incorporates 23 items in areas such as physical, emotional, social and school 
functioning. Each item is scored on a 5-point Likert scale from 0-4 except for the young child version, which 
is scored on a 3-point scale. Total point scores can then be converted to a scale ranging from 0-100. 
Psychometric analysis has revealed construct validity and internal consistency in both healthy children and 
children with brain tumours.
228,229
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Statistical Analysis 
 In order to compare both balance abilities and HRQOL between survivors of childhood 
posterior fossa brain tumours and healthy controls, descriptive statistics (i.e. mean and standard 
deviation) were first calculated and then Mann-Whitney U tests were applied. Due to the non-
parametric nature of the test scores, a Spearman’s rank correlation coefficient (ρ) was used to 
determine the association between balance abilities and HRQOL for the experimental group. All data 
was analyzed using SPSS® statistical analysis software. 
 
Results: 
Balance abilities 
 The mean scale scores for the balance subtest of the BOT-2 were 9.50 (SD=3.94) for the 
experimental group and are indicative of a balance deficit, as they fall in the below average category. 
Performances of the experimental group were significantly worse than those of the control group, who 
had a mean of 15.67 (SD=4.55), placing them in the average category (p=0.004) (Figure 2 (p.68)). On 
the PBS, mean scores for the experimental group (mean=55.67, SD=0.82) were similar to those of the 
control group (mean=55.83, SD=0.41) (Figure 2 (p.68)). All but two subjects obtained the maximum 
score of 56 for the PBS. Scores for all participants are noted in Table IV (p.69). 
 
Figure 2: Mean balance scores in both groups 
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69 
 
Table IV: Subject characteristics and individual scores for all participants 
Experimental Group 
 Characteristics Balance  
Scores 
PedsQL4.0 Self- 
Report Scores 
PedsQL4.0 Parent- 
Report Scores 
Subject Age at  
Evaluation 
Age at  
Diagnosis 
Pathology Chemo- 
therapy 
Radiation 
Therapy 
BOT-2 PBS Total 
Score 
Physical 
 Domain 
Total 
Score 
Physical  
Domain 
E01 14y10m 5y2m MB Y Y 3 54 78.3 75 79.4 78.6 
E02 8y2m 6y5m JPA N N 13 56 97.8 100 83.7 100 
E03 10y3m 5y6m MB Y Y 8 56 84.8 87.5 80.4 84.4 
E04 7y11m 4y4m EPY N Y 12 56 67.4 87.5 80.4 100 
E05 15y2m 11y3m JPA N N 13 56 96.7 100 97.9 100 
E06 18y0m 8y1m JPA N N 8 56 85.9 100 87 100 
 Mean 9.50 55.67 85.15 91.67 84.80 93.83 
SD 3.94 0.82 11.46 10.21 7.01 9.73 
Control Group 
  Balance Scores PedsQL4.0 Self- 
Report Scores 
PedsQL4.0 Parent- 
Report Scores 
Subject Age at  
Evaluation 
BOT-2 PBS Total Score Physical 
 Domain 
Total Score Physical  
Domain 
C01 15y10m 22 56 85.9 96.9 93.5 100 
C02 8y11m 11 56 90.2 96.9 82.6 87.5 
C03 9y8m 20 55 93.5 100 94.6 100 
C04 8y11m 15 56 81.5 84.4 93.5 93.8 
C05 16y9m 15 56 80.4 90.6 66.3 84.4 
C06 17y1m 11 56 93.4 100 95.7 100 
 Mean 15.67 55.83 87.48 94.80 87.70 94.28 
SD 4.55 0.41 5.78 6.14 11.51 6.96 
Abbreviations used: MB = medulloblastoma, JPA = juvenile pilocytic astrocytoma, EPY = ependymoma, BOT-2 = Bruininks-Oseretsky Test of 
Motor Proficiency (2
nd
 ed.), PBS = Pediatric Balance Scale, PedsQL4.0 = Pediatric Quality of Life Inventory Generic Core Scales 
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Quality of Life 
 Mean total scores on the PedsQL4.0 Generic Core Scales self-report were 85.15 (SD=11.46) 
for the experimental group and 87.48 (SD=5.78) for the control group. Mean parent-report total scores 
were 84.80 (SD=7.00) for the experimental group and 87.70 (SD=11.51) for the control group. The 
mean physical dimension scores on the self-report versions were 91.67 (SD=10.21) for the 
experimental group and 94.80 (SD=6.14) for the control group. Mean parent-reported physical scores 
were 93.83 (SD=9.73) for the experimental group and 94.28 (SD=6.96) for the control group. Scores 
for each dimension are presented in Figure 3 (p.70). 
 
Figure 3: Mean PedsQL4.0 scores in both groups 
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Association between quality of life and balance abilities 
 Due to the ceiling effect of the PBS, a Spearman rank correlation coefficient was calculated 
for the BOT-2 balance subtest scale scores and the physical dimension score of the PedsQL4.0. For the 
experimental group, it was found to be ρ=0.715 denoting an association. 
 
Discussion: 
 The first objective of this exploratory study was to determine the balance abilities of survivors 
of childhood posterior fossa brain tumours and compare them to age- and gender-matched controls. 
Based on normative values, survivors' balance scores are indicative of a deficit while the control 
group's balance abilities are not. Although the sample size is small, the difference between the two 
groups is significant and clinically meaningful. This supports the notion that survivors demonstrate 
poorer balance abilities. These results are similar to the only other brief report found in the literature 
investigating balance among a group of thirteen survivors of childhood brain tumour using the BOT-
2.
224
 Thus it would seem that the balance subtest of the BOT-2 is sensitive to detect differences in 
balance abilities between survivors of childhood posterior fossa brain tumour and healthy controls. 
 Evaluation of balance abilities using the PBS demonstrates a ceiling effect for both groups as 
all but two subjects achieved the maximum score of 56. The PBS does not appear to be sensitive 
enough to detect balance differences in these groups. Ceiling effects have also been reported in 
typically-developing children older than 7 years old.
168
 The developers of the PBS recommend that the 
BOT-2 be used when investigating balance in children over the age of 6 years old.
168
 In the present 
study, the balance subtest of the BOT-2 does reflect balance difficulties in survivors of childhood 
posterior fossa brain tumours. The results of the present exploratory study suggest that the BOT-2 is a 
more appropriate tool to use in clinical practice and in research protocols to assess balance abilities in 
survivors of childhood posterior fossa brain tumours than the PBS. 
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 The second objective of this study was to compare HRQOL in survivors of childhood posterior 
fossa brain tumours to age- and gender-matched controls. All self-report and parent-report total scores 
and all dimension scores for survivors fall within the published norms and scores were quite similar 
between self- and parent-report versions.
228
 This is similar to other studies that report survivors score 
their HRQOL using the PedsQL4.0 Generic Core Scales similarly to their parents.
82,231
 In the present 
study, scores between survivors of childhood posterior fossa brain tumours and controls denote no 
major differences in HRQOL despite differences in standing balance abilities. This is compatible with 
another study that reported that survivors of low-grade cerebellar astrocytoma ranked their HRQOL 
the same or higher as controls.
82
 However, some other studies have documented lower HRQOL in 
survivors of all forms of brain tumours.
231
 This difference could be attributed to the fact that the 
present study includes subjects with tumours in a specific region of the brain whereas other studies 
include a broader range of brain tumours, which may reflect a more heterogeneous group. 
 The third objective was to investigate any associations between balance scores and HRQOL. 
To this end, as the PBS demonstrated a ceiling effect, only the balance subtest score of the BOT-2 was 
compared to the physical dimension score of the PedsQL4.0. In the experimental group, there appears 
to be an association between balance scores and the physical HRQOL indicating better balance can 
contribute to better HRQOL. These results need to be interpreted with caution due to our very small 
sample size but definitely warrant further investigation. To the best of our knowledge, no other studies 
have investigated the relationship between balance scores and HRQOL.  
 One of the major limitations of this study is the small sample size which restricts the 
generalizability of the present results. However, as this was an exploratory study with some interesting 
results, future research is warranted to further elucidate balance abilities in survivors of childhood 
posterior fossa brain tumours. Another limitation of this study was the fact that the evaluator was not 
blinded to which group the participant belonged. However, owing to the standardized nature of the 
tests used, this may not have been too much of a confounding factor. 
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Conclusion: 
 This exploratory study showed a statistically and clinically meaningful balance deficit in a 
small group of survivors of childhood posterior fossa brain tumours as compared to an age- and 
gender-matched control group. This difference was best demonstrated using the balance subtest of the 
BOT-2. Future studies should be geared towards evaluating the psychometric properties of this tool in 
this population. This study also demonstrated that quality of life scores, using the PedsQL4.0 Generic 
Core Scales, were very similar between the two groups and that for all subjects the self-report and 
parent-report scores were comparable. For survivors, higher balance scores on the BOT-2 reflected 
higher scores in the physical dimension of the PedsQL4.0.This would need to be more deeply 
investigated before any specific conclusion can be drawn. 
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PREFACE: 
 In order to quantify dynamic standing balance utilizing laboratory measures in survivors of 
childhood brain tumours, we needed to develop a new approach. As mentioned in the literature review, 
there exist few methods to evaluate dynamic standing balance using a force platform in children. 
Therefore, it is unknown which set-up, tasks or parameters are best suited to fully describe dynamic 
balance abilities in survivors of childhood brain tumours. In the present study, a new method had to be 
assessed. The concept for the method and tasks stems from previous studies into the limits of stability 
conducted by several researchers, including Dr. Dany Gagnon, on sitting and standing balance in 
individuals with a spinal cord injury and able-bodied controls. Although the population of survivors of 
childhood brain tumours is extremely different from that of spinal cord injured people, the task of 
reaching was thought to be simple enough for children to follow. 
 The programs that were used to collect and analyze the data were already available at the 
Pathokinesiology laboratory at the Institut de réadaptation Gingras-Lindsay-de-Montréal. The testing 
protocol (i.e. testing position, instructions, visual feedback, etc...) attempted to combine any 
recommendations found in the literature. What required further development was the data analysis. 
Although some parameters used in the spinal cord injured population were applicable, as our testing 
was done in a standing position, additional outcome measures needed to be developed in order to more 
completely analyze the COP movements. 
 Unfortunately, due to circumstances with the equipment, we were unable to test a large 
number of participants with the force platform. Only four of the experimental group were tested and 
owing to a variety of reasons, much of their data was incomplete and could not be analyzed. Some of 
these reasons included, inconsistencies in when the recording of the trial was started, inconsistent 
positioning of the feet, difficulty standardizing the reaching method, calibration difficulties and 
inability to properly construct the base of support. After all the testing had been completed, only one 
participant's data could be easily and completely analyzed. Therefore it was decided to present the 
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laboratory evaluation of dynamic balance as a proof of concept paper in order to elaborate the methods 
and outcome measures. 
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Abstract: 
Few studies have attempted to quantify standing balance in survivors of childhood posterior fossa 
tumours via use of force platforms. Most evaluate balance under quasi-static standing conditions only. 
Objective: This proof of concept aims to describe a novel method for quantifying the comfortable 
limits of stability (LOS) in standing in a survivor of childhood posterior fossa tumour. Methods: The 
participant stood at the centre of a force platform and reached as far as possible along eight different 
directions, separated by 45° intervals. The main outcome measures were: Precision Index-Angle, Precision 
Index-Distance, Direction-Specific Index of Stability and Overall Stability Index. Results: The results for the 
precision indices were contradictory with the participant demonstrating relatively precise displacements in the 
required direction but  less precise trajectories toward their maximal displacement. The Overall Stability Index 
confirmed that the participant's COP excursions remained within 30% of their BOS. It is difficult to assert if 
the laboratory measures highlight balance difficulties as no normative data exists for the outcome 
measures. Conclusion: Although requiring further development, the comfortable LOS offers a promising 
new method to evaluate dynamic standing balance in survivors of childhood posterior fossa tumours that 
could be used as a complement to traditional quasi-static techniques. 
 
Keywords: dynamic postural control, limits of stability, evaluation, pediatrics 
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Introduction: 
 Tumours of the central nervous system represent the second most common form of pediatric 
cancer and the most common solid tumour found in children and adolescents.
15
 It has been reported 
that up to 50% of these tumours occur in the posterior fossa, a region of the brain that includes the 
cerebellum.
15
 The cerebellum plays a critical role in the control of balance.
9
 Therefore, damage to the 
cerebellum and surrounding structures could lead to balance deficits. To date, only a few studies have 
attempted to quantify standing balance in survivors of childhood posterior fossa tumours via use of 
force platforms in laboratory or clinical environments. 
 Standing balance commonly refers to a person's ability to maintain their centre of pressure 
(COP) within the limits of the base of support (BOS), defined as the contours of their feet, when 
maintaining a bipodal standing position.
114
 The location of the COP reflects where the vertical ground 
reaction force acts upon the centre of mass (COM) within the BOS to control standing balance.
114
 The 
height of the COM and the dimension of the BOS are closely linked within the concept of postural 
stability. It is recognized that the larger the BOS, for a constant height of the COM, the larger the area 
in which the COP can oscillate safely. Consequently, this minimizes the risk of losing balance. These 
COP oscillations are proportional to inertial effects and to the change in position of the COM when a 
person moves in standing.
117
 
 An alternative way to explain the relationship between the COM and COP is the inverted 
pendulum model proposed by Winter et al. This model states that the difference between the location 
of the COM and the COP is proportional to the acceleration of the COM.
117
 Therefore, the COP 
trajectory provides information about the oscillations of the COM within the BOS and can be 
characterized using different methodological approaches in standing.
186,187
 A lack of consensus in these 
approaches stems from the fact that there is no normative pattern for COP movement and that there 
exists a plethora of COP variables that are inter-related and often redundant.
185-187
 Nonetheless, force 
platforms are essential to measure the COP, especially when no kinematic data is recorded. Force 
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platforms may also offer the capability to quantify more subtle standing balance deficits or those not 
detected by clinical outcome measures. 
 Most of the studies investigating balance in survivors of childhood posterior fossa tumours 
using force platforms evaluate balance under quasi-static standing conditions only.
11,13,14
 Others 
attempt to introduce a postural perturbation component by tilting the force platform in the anterior and 
posterior directions while requiring that the participant maintain a steady standing position.
10 
All of 
these methods for evaluating quasi-static and dynamic balance abilities may not translate into 
functional tasks, which often require self-initiated movements in a multitude of directions while 
maintaining a fixed BOS. 
 Another method used to incorporate a dynamic component to standing balance assessment 
with a force platform is the limits of stability (LOS). The LOS can be described as the maximum 
possible displacement of the COP without having to modify the BOS.
114
 To measure the LOS, some 
studies employ an approach requiring the participants to trace a circle with the largest radius possible 
with their head/arm/trunk segment by leaning as far as they can in standing while maintaining both feet 
in contact with the force platform.
198,199
 This may not be feasible in children as the concept could be 
difficult to understand especially when no visual feedback is provided. An additional method proposed 
for evaluating dynamic standing balance is the multi-directional reach test, whereby the distance a 
person is able to reach in various directions (forwards, backwards, right and left) is measured.
232
 Using 
COP data to analyze the multi-directional reach test may provide complementary and meaningful 
information on the neuromotor strategies a person uses to complete the tasks. A previous study 
investigated the multi-directional reach test while healthy adult participants stood on a force platform 
and found that it appears to measure the same construct of balance as the LOS.
200 
In fact, the COP 
excursions were correlated with the distance reached in all directions except for backwards.
200
 
Reaching in various directions while data is collected via a force platform has also been used in a few 
studies to evaluate sitting balance in healthy adults as well as in adults with neurological 
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impairment.
201,202,233
 This technique may be useful to assess standing balance in children and 
adolescents as well as survivors of childhood posterior fossa tumours as instructions appear relatively 
simple for children to understand. Providing real-time visual feedback of the COP may also facilitate 
comprehension as children rely heavily on their visual system in order to maintain balance.
123
 
 To the best of our knowledge, utilizing a multi-directional reach test to assess dynamic 
standing balance abilities while providing visual feedback has not yet been done in survivors of 
childhood posterior fossa brain tumour. Thus, this proof of concept aims to describe a method used to 
quantify the comfortable LOS in standing and to report results computed in a survivor of childhood 
posterior fossa tumour. 
 
Methods: 
Participant: 
  A male survivor of childhood posterior fossa tumour (age=ten years, three months; 
height=146.3cm; weight=39.4kg; right handed) participated in this study. He was diagnosed with a 
medulloblastoma, which was surgical resected, at the age of five years, six months, which was 
followed by radiation therapy and chemotherapy. His lower extremity range of motion as measured 
with an inclinometer showed some limitations in ankle dorsiflexion (right=3°; left=2°) and 
hyperextension in both knees (10° bilaterally). Evaluation of lower extremity strength and sensation 
confirmed the sensorimotor integrity of the lower extremities. The participant's balance abilities were 
assessed by the nine item balance subtest of the Bruininks-Oseretsky Test of Motor Proficiency - 
second edition (BOT-2), a commonly used pediatric clinical balance measure. This test includes tasks 
such as standing on one foot with eyes open and closed, walking along a line and standing tandem on a 
balance beam. As the participant obtained a normalized scale score of 8, his balance abilities would be 
classified as below average based on the fact that the mean normalized scale score is established at 15 
(SD=5). 
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 This study was approved by the research ethics board of the Montreal Children’s Hospital of 
the McGill University Health Centre and both informed consent and assent were obtained prior to 
participation in this study. 
 
Procedure: 
 The participant stood barefoot at the centre of a portable Bertec force platform (FP-4060-05-
PT; Bertec Corporation, Columbus, OH)  used to continuously record the tri-axial components of the 
ground reactions forces at 600Hz. The outlines of his feet were traced over the force platform with a 
dry-erase marker to ensure consistency in position between trials after the participant had self-selected 
his comfortable and habitual foot placement. From this steady starting position, the participant reached 
as far as possible with one arm flexed/abducted to 90° along eight different directions, separated by 
45° intervals while maintaining his balance (Figure 4 (p.82)). For the posterior directions, the 
participant crossed his arms over his chest. The participant bent his head/arm/trunk segment from the 
hips and ankles at a self-selected velocity while keeping his heels down. The expected direction of 
displacement of the COP and the real-time COP position were displayed in front of the participant on a 
computer screen to provide visual feedback and to ensure movement was performed along the proper 
direction. Two repetitions were randomly recorded in each direction for a total of sixteen trials. Each 
trial had to be completed within a 15 second period. Upon completion of the test, a minimum of 50 pressure 
points were digitized (from the traced outlines) while the evaluator applied a vertical force with a rigid and 
heavy metallic rod (20kg) to compute the boundary of the BOS. The sixteen COP time series recorded in the 
horizontal plane, reflecting a combination of the anteroposterior (Fx) and mediolateral (Fz) ground reaction 
force directions within the platform referential, were filtered with a fourth-order Butterworth zero-lag low pass 
digital filter with a cut-off frequency of 10Hz and then down-sampled at 300Hz for analysis. 
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Figure 4: Position of the participant on the force platform and reach directions 
 
 
 
 
 
 
 
 
Main Outcome Measures: 
 The main outcome measures, computed with a MATLAB program developed for the study are 
described below and illustrated in Figure 5 (p.83): 
 
Precision Index - Angle: For each of the eight directions tested, this represents the absolute difference in 
degrees between the targeted direction versus the actual direction of the COP displacements, as determined 
using the initial and maximal COP positions. This can be interpreted as the angle error for each direction 
tested and values exceeding ±10° are defined as demonstrating insufficient precision. 
 
Precision Index - Distance: For each of the eight directions tested, this represents a COP displacement ratio 
between the minimal mathematical distance separating the initial COP position from the maximal COP 
displacement (numerator) and the actual distance travelled by the COP between these two points 
(denominator). Described as a percentage, a value of 100% corresponds to a perfectly linear displacement of 
the COP between the two COP positions whereas a value closer to 0% reflects an extremely arbitrary 
displacement. 
 
Computer Screen 
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Figure 5: Main outcome measures for comfortable limits of stability 
 
 
 
 
 
5A: Precision Indices 
5B: Stability Indices 
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Direction-Specific Index of Stability: For each of the eight directions tested, the initial position of the COP 
(COPStart), the furthest position reached by the COP in the indicated direction (COPFinal) and the maximal 
theoretical potential position the COP could have reached to attain the boundary of the BOS in the indicated 
trajectory (COPMaximal) were computed. Then, the direction-specific stability index, expressed as a percentage, 
was calculated for each of the eight directions (Eq.1): 
Eq.1: Direction − Specific Index of Stability  %  
=  
COPFinal −  COPStart
COPMaximal −  COPStart
 x 100 
Overall Stability Index: Incorporating all directions tested, an overall stability index representing the area 
defined by an ellipse (COPArea) convexly fitting the mean furthest position reached by the COP in each of the 
eight directions tested, normalized against the area of the BOS (BOSArea), was calculated and expressed as a 
percentage (Eq.2): 
Eq. 2: Overall Stability Index  %  
=   
COPArea
BOSArea
 x 100 
Results: 
 A tracing of the COP displacements in each of the eight directions are shown in Figure 6 (p.85). All 
outcome measures computed for the participant in each of the eight directions tested and the overall means for 
each index are presented in Table V (p.86). With regards to the Precision Index-Angle, the participant showed 
fairly precise displacements, as his deviations were less than 10° for all directions. Conversely, for the 
Precision Index-Direction, the participant's displacements lack precision in most directions with values 
ranging between 23.2 and 38.8 for all directions. The Direction-Specific Stability Index reached values 
ranging between 53% and 77%. Finally, the Overall Stability Index confirmed that the participant's overall 
COP excursions remained within 30% of their BOS. 
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Figure 6: Tracing of COP displacements 
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Table V: Results for main outcome measures on comfortable limits of stability 
 
Main Outcome Measures Directions of COP displacement 
 Ant Right Ant-
Lat 
Right Lat Right 
Post-Lat 
Post Left 
Post-Lat 
Left Lat Left 
Ant-
Lat 
Overall 
Mean 
Precision Index- Angle (º) 7.3 2.3 3.9 1.2 3.9 1.3 4.0 4.7 3.6 
Precision Index-
Distance(%) 
26.6 24.7 27.5 27.9 38.8 36.1 26.1 23.2 28.9 
Direction-Specific Stability 
Index(%) 
58.1 59.5 64.4 53.6 77.0 55.4 66.2 63.7 62.3 
Overall Stability Index Area COPMaximal 
(cm
2
) 
Area BOS 
(cm
2
) 
Overall Stability 
Index (%) 
      
        19.1 64.4 29.7       
Abbreviations used: COP=Centre of pressure, Ant=Anterior, Lat=Lateral, Post=Posterior, BOS=Base of support 
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Discussion: 
 The objective of this exploratory study was to present a novel way to quantify the comfortable 
LOS in standing in a survivor of childhood posterior fossa tumour. This technique could be used as a 
complement to the quasi-static tests that are routinely conducted on a force platform in order to have a 
more comprehensive assessment of balance abilities. In our participant, the clinical tool the BOT-2 
revealed below-average balance abilities. It is difficult to assert if the laboratory measures also 
highlight difficulties as this is a new method and no normative data exists for our outcome measures. 
Future studies would be necessary to establish how the outcome measures quantify balance in a 
pediatric population. 
 The testing of this new method revealed several ways that it could be improved in the future. 
Firstly, the tasks in the present study may not be challenging enough as the participant remained in 
their comfortable LOS. Also, the outcome measures may not reflect how difficult the participant found 
the task as there was no way to gauge what level of effort they were using. A participant's level of 
effort could potentially reveal how confident they are in their balance abilities. Had the instructions 
included the command to not only displace the COP as far as possible but to go as fast as possible too, 
this could reveal how confident they are in their balance abilities. Furthermore, this information on 
COP velocity in conjunction with maximal excursion for a given direction (i.e. Direction-Specific 
Index of Stability), may provide an idea of how much balance reserve is available for a participant. 
This could translate into how a participant is able to perform in response to perturbations (i.e. reactive 
postural adjustments) and may offer a better assessment of dynamic balance abilities, especially in a 
more functional context. It appears that refinement is needed to these new outcome measures of the 
comfortable LOS. 
 A limitation of this exploratory study was that foot placement was self-selected and not 
standardized so starting points on the platform would not be identical between subjects if we would 
like to compare performances in future studies. Along with standardizing foot placement, pressure 
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switches may be fixed under participants' heels in order to ensure that they remain in contact with the 
platform at all times. This would ensure that no compensation would be allowed, thereby reflecting the 
participant's true comfortable LOS. Adding an instrumented pressure mat to the set up would allow for 
more precise measurement of the BOS and weight distribution, in turn providing more accurate 
analysis of the weight shifting during reaching. Other possible improvements to the comfortable LOS 
could include adding a measure to account for COP velocity as this would provide extra information 
on stability, as previously discussed. Additional practice trials may also be required as children and 
adolescents may not necessarily understand what is asked of them right away. Finally, adding a target 
placed at shoulder height in each of the tested reaching directions may provide another method of 
feedback to ensure movement is in the expected directions. 
 To conclude, although requiring further development, the comfortable multidirectional LOS offers a 
promising new method to evaluate standing balance in survivors of childhood cerebellar tumours. This 
technique could be used as a complement to traditional quasi-static outcome measures frequently used in 
clinical practice in order to have a more comprehensive picture of balance abilities. In addition to refinement 
of the technique, future research should be geared to testing the psychometric properties of the comfortable 
LOS in the pediatric population.  
 
 
 
 
 
 
 
 
Chapter 8: Additional Results 
8.1 Clinical Variables 
Mean scores for both groups’ lower extremity ROM and strength are presented in Table VI 
(p.89). Visual inspection of these results, as well as those for distal lower extremity sensation, denotes 
no major differences between the groups. Although it was intended that these variables possibly be 
used to explain differences in balance abilities, our small sample size limited their use in analysis. 
 
 
Table VI: Mean lower extremity range of motion and strength 
 ROM (in degrees)  Strength (in N) 
 Exp. 
Group 
Cont. 
Group 
 Exp. 
Group 
Cont. 
Group 
Right Hip Flexion 128.7 118.8 Right Hip Extensors 103.6 117.5 
Left Hip Flexion 130.7 118.0 Left Hip Extensors 96.7 110.5 
Right Knee Flexion 143.5 135.7 Right Hip Abductors 98.5 137.6 
Left Knee Flexion 146.5 141.5 Left Hip Abductors 93.8 143.8 
Right Knee Extension 4.7 0.7 Right Knee Extensors 122.2 137.2 
Left Knee Extension 3.7 0.0 Left Knee Extensors 127.9 117.2 
Right Ankle Dorsiflexion 9.8 7.7 Right Ankle Dorsiflexors 136.6 121.6 
Left Ankle Dorsiflexion 10.3 6.5 Left Ankle Dorsiflexors 130.3 117.1 
Right Ankle Plantarflexion 50.0 51.7 Heel Raises (number) 26.3 28.5 
Left Ankle Plantarflexion 54.2 51.5    
Abbreviations used: ROM=Range of Motion, N=Newton, Exp=Experimental, Cont=Control 
 
 
 
 
Chapter 9: Discussion 
 In this section, the main findings of this thesis will be summarized and further discussed. This 
will be followed by the clinical implications and limitations of this study as well as future directions 
for research in the area of rehabilitation for survivors of pediatric CNS tumours. 
 
9.1 Summary of Key Results 
 A structured literature review was conducted in order to elucidate what is known with regards 
to balance outcomes in survivors of pediatric cancers. This was done to guide the present research 
study where the main objective was to quantify quasi-static and dynamic standing balance in survivors 
of PFTB using clinical and laboratory balance outcomes measures and to compare them to healthy, 
matched controls. Secondary objectives were to quantify and compare HRQOL between the groups 
and to explore the association between standing balance abilities and HRQOL in the experimental 
group. The results pertaining to these objectives are described below. 
 
 9.1.1 Literature Review 
 The main finding of the literature review into balance outcomes of survivors of pediatric 
cancers, consisting of only ALL and pediatric CNS tumours, was that balance deficits seem to persist 
once treatment has been completed. Based on the OCEBM Levels of Evidence, these studies were of 
low quality. Some limitations of the available literature were the lack of clinically-oriented studies, the 
assessment of dynamic balance was limited and how the balance deficits affect everyday lives was not 
addressed. 
 
 9.1.2. Experimental Group Characteristics 
 A highly interesting observation was that all participants in the experimental group were male. 
Their age at diagnosis of a PFBT ranged from 4 years and 3 months to 11 years and 3 months 
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(median=6 years) and their time since completion of treatment ranged from 20 to 119 months 
(median=44.5 months). Based on the WHO classification of CNS tumours, two were diagnosed with 
medulloblastoma, three with juvenile pilocytic astrocytoma and one with ependymoma. All 
participants received surgical intervention, while the subject with ependymoma received additional 
radiotherapy and the two with medulloblastoma received both adjuvant radiotherapy and 
chemotherapy. 
 
 9.1.3. Balance Abilities 
 Using the clinical outcome measures, the scores on the PBS were similar for both the 
experimental and control groups and demonstrated a strong ceiling effect. Scores on the balance 
subtest of the BOT-2 were found to be significantly different between the groups. This difference was 
a clinically meaningful one as each groups’ scores were classified in two distinct descriptive 
categories.  
 In order to calculate the power of the present study the following points were considered: 1) 
our primary outcome measure was the balance subtest of the BOT-2; 2) there were 6 participants per 
group; 3)the experimental group had a mean of 9.50 (SD=3.94) and the control group had mean of 
15.67 (SD=4.55) on the balance subtest of the BOT-2 and; 4) the desired sign level was 0.05. Based on 
these considerations, the power of the research study was calculated at 75.2. 
 A new method was utilized to assess dynamic standing balance using laboratory outcome 
measures and the comfortable LOS. With regards to the Precision Index-Angle, the participant showed 
fairly precise displacements. Conversely, for the Precision Index-Direction, the participant's displacements 
lack accuracy in most directions. The Direction-Specific Stability Index values varied depending on the 
direction and the Overall Stability Index demonstrated that the participant's COP excursions remained within 
30% of their BOS. 
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 9.1.4. Health-Related Quality of Life 
 All scores on the PedsQL4.0 Generic Core Scales were within the normative ranges for the 
experimental and control groups for both the self- and parent-reported versions.
228
 Comparisons of 
scores on the self- and parent-reported versions for all participants were quite similar. 
 
 9.1.5. Association Between Balance Abilities and Health-Related Quality of Life 
 In order to determine the association between balance abilities and HRQOL, only the BOT-2 
was used as the PBS demonstrated a ceiling effect. Furthermore, only the physical dimension scores of 
the PedsQL4.0 were used as this was felt to be the most pertinent domain to relate to balance abilities. 
A Spearman's rank correlation coefficient was calculated for the experimental group and found to be 
ρ= 0.715 denoting an acceptable association. 
 
9.2 Discussion of Key Results 
 9.2.1. Experimental Group Characteristics 
 With regards to the experimental group, it is noteworthy that only male participants were 
recruited. Although the literature suggests that males are more often diagnosed with CNS tumours than 
females in the pediatric population, the difference is only slight.
15
 However, the fact that the study 
sample is only male, the results may not be readily applied to all PFBT survivors as some studies do 
find differences in balance abilities between genders in typically-developing children and 
adolescents.
148,149,234,235
 Another interesting feature of the experimental group is the fact that the most 
common pathologies are all represented: juvenile pilocytic astrocytoma, medulloblastoma and 
ependymoma.
7
 This makes the present research study more generalizable to all PFBT tumours as no 
particular pathology is more prominent. Likewise, the treatments received by the experimental group 
correspond to the standards described in the literature, assisting the applicability of the results.
20,48
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 9.2.2. Balance Abilities 
 Although sample size was small, the power of the study was fairly good. There is a significant 
difference in balance abilities as measured by the BOT-2 between survivors of pediatric PFBT and 
healthy controls. Moreover, this difference is a clinically meaningful one as the score for PFBT 
survivors places them in the below average category based on the normative data while the controls 
scored in the average range. Interestingly these deficits can persist for years after treatment is 
completed as in our sample, time off treatment varied from just under 2 years to almost 10 years post-
treatment (Median = 3.7 years). This highlights the fact that standing balance can remain affected long 
after treatment is completed. As mentioned previously in the review article, literature is sparse 
investigating balance outcomes in survivors of pediatric CNS tumours using clinical outcome 
measures.
236
 Nonetheless, the results of the present study are comparable to the only other study found 
in the literature that investigated standing balance using the BOT-2 in children having undergone 
resection of PFBT.
224
 
 On the other hand, the PBS demonstrated a ceiling effect for all participants as most achieved 
a maximal score of 56/56. For that reason, the PBS is likely not sensitive enough to detect balance 
difficulties in survivors of pediatric PFBT. In the present study, it was thought that PFBT survivors’ 
could have greater balance difficulties than what was found so the PBS was initially chosen in order to 
be able to measure varying levels of balance abilities. The developers of this tool also found a ceiling 
effect in typically-developing children over the age of 7 years old and therefore recommend the PBS 
be used to assess balance abilities in children aged 3 to 6 years old.
168
 The youngest participant in the 
present research study was aged 7 years and 11 months.  
 When using laboratory measures to assess dynamic standing balance, the results of the 
comfortable LOS were contradictory for certain parameters. This could be due to the fact that the 
outcome measures may not reflect how difficult a participant found the task. There was no way to 
gauge what level of effort they were using. As discussed in the review article, there is only one other 
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study that attempts to assess dynamic standing balance in survivors of pediatric CNS tumours utilizing 
laboratory measures.
132
 It is impossible to compare results of the study by Ilg et al. (2008) to the 
present study's comfortable LOS as kinematic analysis was used in the evaluation of step width and 
lateral sway during gait. Although the comfortable LOS attempts to assess balance in a dynamic 
manner, it may not automatically reflect the anticipatory and reactive postural adjustments required 
when undertaking functional tasks, such as gait. 
 
 9.2.3. Health-Related Quality of Life 
 In the present research study, overall HRQOL appears to be similar between the survivors of 
pediatric PFBT and controls. This is analogous to several other studies that have found no differences 
in HRQOL for survivors of pediatric CNS tumour, using a variety of tools, as compared to normative 
values.
82,93,106
 One study even demonstrated that survivors reported their HRQOL as higher than a 
group of typically-developing children.
111
 On the other hand, there are reports that demonstrate the 
opposite; that survivors rate their HRQOL as lower.
75,109,214,231
 These conflicting findings are likely due 
to the fact that pediatric CNS tumour survivors are a very heterogeneous group and participant 
characteristics vary widely between studies in terms of types and locations of the tumours as well as 
types of treatment received by the participants. If we focus upon only the studies investigating 
HRQOL in survivors of tumours located exclusively in the posterior fossa, it is noted that this 
disagreement in the results still exists as two studies report similar HRQOL while another reports 
lower HRQOL.
82,93,109
 
 Additionally, both participants and their parents express very similar scores on the PedsQL4.0. 
This would imply that the parents of survivors of pediatric PFBT in this study have good insight into 
how their child is doing. Other studies that investigated this generally found good agreement between 
parent and proxy reports of the PedsQL4.0.
82,231
 In future studies, should a survivor not be able to 
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answer the questionnaire due to decreased cognitive abilities, which is quite possible as cognitive 
deficits have been established in this group, parent-reports can be relied upon to assess HRQOL. 
 Overall, from the present study, it can be believed that survivors of pediatric PFBT have a 
relatively normal quality of life in all spheres, which is an encouraging picture. However, this study 
only included participants that were able to stand independently without the use of an assistive device. 
This represents a potential selection bias as survivors with more severe physical disabilities and 
potentially lower HRQOL were excluded. 
 
 9.2.4. Association Between Balance Abilities and Health-Related Quality of Life 
 Based on the very preliminary results of this study, there appears to be an association between 
balance scores and physical HRQOL in survivors of pediatric PFBT. This may possibly indicate that 
better balance can contribute to better HRQOL. To the best of our knowledge, no other studies have 
investigated the relationship between balance scores and HRQOL. Nevertheless, these results need to 
be interpreted with great caution especially due to the small sample size and that the physical summary 
scores of survivors of pediatric PFBT fell within the normative values. 
 
9.3 Clinical Implications 
 This study, along with the review article presented in this thesis, has shown that some 
survivors of pediatric PFBT demonstrate balance difficulties but have relatively normal quality of life 
when compared to matched controls. Various outcome measures were used to establish these findings; 
however, none have their psychometric properties substantiated in this population. The clinical 
implications of this are discussed below. 
 
 Although the incidence of CNS tumours in the pediatric population remains low in Canada, 
medical management has improved and survival is increasing with 5-year survival rates currently 
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reaching 71%.
1
 While literature remains sparse with regards to long-term physical outcomes in this 
population, physiotherapists working with this group may notice persistent balance deficits. This is 
especially true in those with tumours occurring in the posterior fossa, which represents the most 
common location of pediatric CNS tumours.
6,7,15,26,27
 It will become imperative to document the impact 
of these improved medical outcomes and new treatment regimens on long-term outcomes in survivors 
of pediatric CNS tumours. This research study may be a step towards recognizing the persistent 
physical difficulties faced by survivors. 
 That survivors of pediatric PFBT demonstrate ongoing balance deficits in the present study, in 
some cases for years after treatment has been completed, likely supports the need for continued 
physiotherapy follow-up in this population. It could be recommended that all survivors of PFBT, and 
possibly all other CNS tumours, be screened for their balance abilities. At the Montreal Children's 
Hospital, this would imply having a physiotherapist present in the neuro-oncology clinics along with 
the medical and nursing professionals, in order to make this clinic truly interdisciplinary.  There is a 
growing trend in many centres across North America, where special clinics are being implemented to 
evaluate and manage long-term difficulties in survivors of all forms of pediatric cancer, including CNS 
tumours. A more comprehensive evaluation of physical, cognitive and psychosocial outcomes in 
survivors would be achieved if the Montreal Children's Hospital had such a clinic that included not 
only physiotherapists but occupational therapists, social workers and psychologists as well. 
 Should a physiotherapist more proactively evaluate standing balance in survivors of PFBT in 
the neuro-oncology clinic, from the results of the present study, it would appear the balance subtest of 
the BOT-2 would be the most appropriate tool to use in order to screen for balance difficulties. 
Although little is known with regards to psychometric properties of the BOT-2 in this population, it 
remains quick to perform, requires little equipment or space and as such could easily be incorporated 
into the clinic visit. There are possibly other tools that could be used to screen for balance deficits in 
survivors of pediatric PFBT such as those discussed in the literature review that would warrant further 
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investigation. If screening reveals difficulties, a more thorough balance assessment would be indicated 
and could include items such as gait analysis or dual-task balance and cognitive activities, which is 
currently an emerging area of research in postural control. Although it is likely more efficient to screen 
only those survivors of pediatric PFBT that may be at higher risk for developing balance deficits, the 
small sample size in the present study did not allow for this analysis. The literature does not further 
clarify this matter as the two studies investigating associations between clinical and treatment variables 
and balance abilities offer contradictory conclusions.
12,88
 Nevertheless, should screening reveal 
significant balance deficits, survivors of pediatric PFBT should be referred for appropriate 
rehabilitation services. 
 Unfortunately this group is often not accepted for intensive in- or out-patient functional 
rehabilitation for a variety of reasons. The fact that survivors of pediatric PFBT demonstrate relatively 
normal quality of life in the present study, although encouraging, would likely substantiate the 
rehabilitation centres’ refusal to provide services for this population. But this study also suggests that 
better balance abilities are correlated with better scores in the physical dimension of HRQOL. 
Therefore, it appears beneficial to improve balance abilities in survivors of pediatric PFBT. If 
rehabilitation centres are not planning to develop specialized rehabilitation programs for this 
population, there may be other ways to address these issues. For example, as there are more survivor 
clinics appearing in hospital centres, it will likely fall to them to offer survivor rehabilitation programs 
where groups of survivors, not only of CNS tumours but all forms of pediatric cancers, can participate 
in structured exercise. Unfortunately, the likelihood of this happening is limited by budgetary and 
staffing constraints; therefore, solutions must be found in the community. For example, exercise 
programs could be provided and individualized for survivors of pediatric PFBT. These programs 
should be tailored to the individual survivor and based on their interests so that the exercises could be 
performed either at home possibly via a web-based exercise group, in a gym or incorporated into any 
other physical activity they already participate in. 
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9.4 Limitations 
 The most obvious limitation of the present study is with regards to the sample size. Overall, 
only six participants were recruited to the experimental group and of those, only four were able to be 
assessed using the force platform. There were several contributing factors to this. Firstly, there was an 
unfortunate administrative delay in having the project approved by the Research Ethics Committee that 
was beyond our control. As a consequence, instead of receiving ethics approval at the beginning of the 
summer of 2011, as was originally planned to optimize recruitment as many neuro-oncology clinics 
were being held due to summer holidays, ethical approval was obtained only at the end of August 
2011. Furthermore, there were many cancelled neuro-oncology clinics over the last year due to 
absences by the neurosurgeons. Finally, the clinical nurse specialist who was assisting with recruitment 
took a leave of absence in January 2012, resulting in the need to find an alternate person to assist with 
recruitment. These difficulties coupled with the fact that the force platform had to be returned to its 
owner for use in another project in June 2012, lead to only a few participants being evaluated with this 
equipment. Due to the novel approach used, procedures for collecting the data with the force platform 
may not have been optimal and as previously mentioned, only one participant's data could be easily 
and completely analyzed. This small sample size limited possible statistical analysis and 
generalizability of the results. Be that as it may, the power of the study was fairly good and some 
relevant results were still obtained in this research study and the need to more extensively study using 
the proposed approach was established. 
 Another limitation of this study was the fact that the evaluator was not blinded to which group 
a participant belonged to. Although the outcome measures used were objective and standardized, this 
could always be a potentially confounding factor. Finally, the cross-sectional nature of the study does 
not enable us to investigate how balance abilities evolve over time in survivors of pediatric PFBT. 
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9.5 Future Directions 
Owing to the improved survival rates, it will become essential to continue investigating long-
term physical outcomes, especially balance, in survivors of all forms of pediatric CNS tumours as this 
is a growing group. Balance may be a crucial place to begin as implications for potential deficits on 
functional tasks are evident (e.g. increased risk of falls and slower gait speed). An interesting and 
obvious next step is to conduct longitudinal research in order to see how balance abilities change over 
time. This would help to elucidate as to whether or not there exists a critical time point (or specific 
level of balance ability) to intervene.  
Following this, the next logical step in research, is to investigate ways to treat these balance 
difficulties in survivors of pediatric PFBT. Is it possible for physiotherapists to improve balance 
outcomes and when should they intervene? Future research could be geared into examining the timing 
of physiotherapy interventions and the most effective methods to improve balance abilities in survivors 
of pediatric PFBT. This would help to expand and further define some of the proposals mentioned 
above with regards to programs developed for improving balance abilities in survivors of PFBT. 
Furthermore, should physiotherapists become more formally involved in the follow-up clinics for these 
patients, future research should be geared to measuring the implications of their involvement. Do those 
survivors that are screened by physiotherapy and then provided with intervention have better outcomes 
than those who are not? 
 But in order to make sure physiotherapists properly assess balance abilities in survivors of 
pediatric CNS tumours, tools must be examined for psychometric properties (i.e. validity, reliability, 
responsiveness and minimal detectable change) for use in this population. It is likely easier to begin by 
evaluating existing tools or possibly by combining specific items of the available tools in order to have 
a more comprehensive picture of balance abilities. With regards to laboratory measures, further 
investigation is warranted into the use of comfortable LOS as this is a novel approach to quantifying 
dynamic standing balance not only in survivors of pediatric CNS tumours but in typically-developing 
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children and adolescents as well. LOS outside the comfortable zone may also deserve attention as they 
may be more relevant to balance requirements encountered in daily life. 
 Finally, more collaborative efforts are required in order to improve sample sizes of studies 
involving survivors of pediatric CNS tumours. Much of the literature describing balance outcomes in 
this population, including the present research study, suffers from small sample sizes. This can make 
finding significant results difficult and can possibly lead to hesitation when ones are found. 
Additionally, it is challenging to establish what, if any, associations exist between patient, tumour or 
treatment characteristics and balance abilities. As mentioned above, this could help identify those 
survivors that are more at risk for balance difficulties and would allow physiotherapists to better target 
the screening and the follow-up of their patients. Collaboration between centres, clinicians and 
researchers would drastically improve the quality and quantity of the research conducted in the area of 
not only balance outcomes but also physical outcomes in survivors of pediatric CNS tumours.
Chapter 10: Conclusion 
 There is a growing need to investigate the long-term outcomes in survivors of pediatric CNS 
tumours as medical management of these patients has become more intense in order to improve 
outcomes. Long-term effects of these treatments are currently an emerging area of research. This 
includes any outcomes with regards to physical functioning, which is where physiotherapists are most 
interested. However, this is an area where there has been little investigation using objective, 
standardized outcome measures. 
 This study confirms the fact that many survivors of pediatric PFBT have persistent balance 
deficits, even greater than a year post-treatment regardless of the type of intervention, as noted using 
the BOT-2. This tool appears to be the most able to identify differences between the experimental and 
control groups. The PBS demonstrates a ceiling effect in all participants. For the comfortable LOS, 
only certain outcomes measures suggested balance difficulties. 
 Finally, HRQOL for survivors of pediatric PFBT appears to be within the normative range. 
Higher balance scores were associated with higher scores on the physical dimension of HRQOL in 
survivors of PFBT. This could imply that if balance is improved, for example with continued 
rehabilitation, this could lead to improved quality of life, at least in the physical dimension. Future 
research should focus upon the best ways to screen and manage these balance difficulties, including 
the timing of interventions. More collaborative and longitudinal studies are required. 
 This research study contributes to the expanding literature investigating the long-term 
outcomes in survivors of pediatric CNS tumours. Over the last few decades, the medical management 
and survival outcomes have been the strict focus of research in this population. Excitingly, we are on 
the cusp of a shift of that focus away from solely the medical aspect to a more comprehensive, patient-
centred point of view that includes rehabilitation and societal participation. 
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INFORMED CONSENT 
 
 
Title: Quantification of quasi-static and dynamic standing balance in survivors of pediatric posterior fossa brain 
tumours 
 
Principal Investigator:    Dr Isabelle Gagnon, PhD 
    Researcher, Trauma & Child Development Programs 
    Montreal Children’s Hospital 
Assistant Professor 
School of Physical and Occupational Therapy 
McGill University  
 
Co-Investigators:   Dr Dany Gagnon, PhD,  
Researcher, Centre de Recherche Interdisciplinaire en Réadaptation du Grand 
Montréal 
Assistant Professor 
School of Rehabilitation 
Université de Montréal 
 
Melissa Turner, pht 
Physiotherapist 
Montreal Children’s Hospital 
 
PARENT CONSENT FORM 
 
Purpose and General information 
 
You/your child are invited to participate in a research study about standing balance abilities in children and 
adolescents who have had a brain tumour and how it compares to that of other children who have not had a 
brain tumour.  
 
The purpose of the study is to evaluate standing balance abilities, using two different ways, in children and 
adolescents who have had treatment for a certain type of brain tumour. Their balance will be compared to those 
of other children who have not had a brain tumour. We would like to be able to see which way of testing balance 
is better and we will be able to see if balance abilities are different between those children who have had a brain 
tumour and those who have not. Finally, we would like to see if balance affects a child’s quality of life. 
 
Your participation will involve one visit lasting approximately 90 minutes where your child will be assessed by a 
physiotherapist. We would also like you and/or your child to fill out a simple questionnaire.  
 
In total, we would like to have 40 children participate in this study, with 20 in each group (20 children who have 
had a brain tumour and 20 children who have not). 
 
Study Procedures 
 
This study will be done in a quiet room at the Montreal Children’s Hospital by a qualified physiotherapist, who 
will not know, if possible, what group you child belongs to. First, they will assess the movement, strength and 
sensation of your child’s legs. This will be followed by the balance testing, which will be done several ways. There 
xvi 
 
will be two different physiotherapy tests that ask your child to perform a variety of tasks such as standing on one 
leg or standing on a balance beam. Next, an evaluation of standing balance using a special platform that is 
connected to a computer will be done and will require similar tasks as the physiotherapy tests. Breaks will be 
given at different times during the testing. This part should last approximately 90 minutes. 
 
During one of the breaks, you and your child will be asked to fill out a simple questionnaire regarding their quality 
of life. The questionnaires should take no longer than 15 minutes to complete. 
 
Your child’s hospital records will also be looked at by the investigators to get information needed for the study. 
 
Possible Risks and Discomforts 
 
There are no risks associated with your child’s participation in this study other than the possible frustration and 
upset by your child if they cannot perform the tasks. 
 
Possible Benefits 
 
There are no direct benefits to your child for participating in this study, but he/she may contribute to new 
medical knowledge that may help other children in the future. 
 
Voluntary participation 
 
Your child’s participation is voluntary and you should not feel any obligation to join the study.  You may agree 
now but are free to withdraw your child from this study at any time.  Refusal to join or withdrawal from the study 
will not affect your child’s medical care. 
 
During the course of the study you will be informed of any new information which may affect your willingness to 
have your child continue in this study. 
 
 Confidentiality 
 
All information obtained during the study will be kept confidential as required or permitted by law and will be 
kept for 5 years.  Your child’s personal identity will remain confidential, as your child will only be identified by a 
subject identification number.  
 
Your child’s name and other personal identifying information will not be used in any reports, presentations or 
publications.  Representatives from Health Canada, the Montreal Children’s Hospital Research Institute and the 
McGill University Health Centre’s Research Ethics Office Quality Assurance, may have access to your child’s 
records as it pertains to this study.  The research team will have access to your child’s hospital records. 
 
Contact person 
 
For any questions you may have regarding the research project at any time, you may contact the principal 
investigator, Isabelle Gagnon, at (514) 412-4400 ext. 22001 or the co-investigator, Melissa Turner, at (514) 412-
4400 ext. 22109. 
 
For additional information regarding your child’s rights as a research subject, you may contact the hospital’s 
Patient Representative (ombudsman), Patricia Boyer (514) 412-4400 ext. 22223, who is independent of the 
investigators, and works to protect patients’ rights. 
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Consent 
I have read this information and consent form and have had the opportunity to ask questions which have been 
answered to my satisfaction before signing my name.    I acknowledge that I will receive a copy of the Information 
and Consent Form for future reference.  I agree to have my child participate in the research study. 
 
 
 ______________________________________________________________________________________  
Participant’s name: 
 
 ______________________________________________________________________________________  
Parent or guardian’s printed name: 
 
 ______________________________________________________________________________________  
Parent or guardian’s signature: 
 
 ______________________________________________________________________________________  
Relationship to child: 
 
 ____________________________________________    
Date: (dd/month/yy) 
 
 
_______________________________ 
Name of the person who obtained consent 
 
________________________________ 
Signature of the person who obtained consent   
 
 ________________________   
 Date:     (dd/month/yy) 
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ASSENT FORM (for 7-17 year olds) 
 
Title: Quantification of quasi-static and dynamic standing balance in survivors of pediatric posterior fossa brain 
tumours 
 
Principal Investigator:    Dr Isabelle Gagnon, PhD 
    Researcher, Trauma & Child Development Programs 
    Montreal Children’s Hospital 
Assistant Professor 
School of Physical and Occupational Therapy 
McGill University  
 
Co-Investigators:   Dr Dany Gagnon, PhD,  
Researcher, Centre de Recherche Interdisciplinaire en Réadaptation du Grand 
Montréal 
Assistant Professor 
School of Rehabilitation 
Université de Montréal 
 
Melissa Turner, pht 
Physiotherapist 
Montreal Children’s Hospital 
  
You are invited to participate in a research study about standing balance. 
 
What is this study about? 
The reason we are doing this study is to compare the standing balance of children and teenagers who have had a 
brain tumour to other children who have not. 
 
What will I have to do? 
You will be tested by a physiotherapist at the hospital only one time. The test will last about 90 minutes. The 
physiotherapist will look at how strong your legs are and if you can feel when your foot is touched. Then they will 
test your balance by asking you to do things like stand on one foot or stand on a balance beam. You and your 
parents will also answer some questions about your daily life. 
 
What are the possible risks and discomforts? 
There are no risks involved with taking part in this study, but you may feel frustrated if you have trouble with 
some of the tests. 
 
What are the possible benefits? 
You will not receive any direct benefits but we may learn from the information you provide and we may be able 
to help other children in the future. 
 
What are my options? 
You have the choice to be in this study or not and you should not feel any pressure to agree.  You can agree now 
and are always free to change your mind. No one will be mad at you. Your doctor will still continue to give you 
the care you need, even if you don’t want to be in the study.  
 
During this study you will be told of any new information which may affect you wanting to continue. 
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Who will know what I did? 
All information we get during the study will be kept secret.  Your personal identity will remain secret, and your 
name will not be written on any papers.  Your name and personal information will not be used in any 
presentations. 
 
There may be certain people who are allowed to look at the information but it is only to check and make sure we 
are doing the study properly. The research team will be able to look at your hospital records. 
 
Who can I contact if I have questions? 
Any questions you may have about the research project will be answered.  You can call Isabelle Gagnon, the 
principal investigator, at (514) 412-4400 ext. 22001 or Melissa Turner, the co-investigator, at (514) 412-4400 ext. 
22109 at any time.  
 
Assent 
 
I have read this information and have had the opportunity to ask questions which have been answered to my 
satisfaction before signing my name.    I agree to participate in the research study. 
 
 
 
 
 ______________________________________________________________________________________  
Participant’s name: 
 
 ______________________________________________________________________________________  
Participant’s signature: 
 
 
 ____________________________________________    
Date: (dd/month/yy) 
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In the past ONE month, how much of a problem has this been for you … 
    About My Health and Activities (PROBLEMS 
WITH…) 
Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.  It is hard for me to walk more than one block 0 1 2 3 4 
2.  It is hard for me to run 0 1 2 3 4 
3.  It is hard for me to do sports activity or exercise 0 1 2 3 4 
4.  It is hard for me to lift something heavy 0 1 2 3 4 
5.  It is hard for me to take a bath or shower by myself  0 1 2 3 4 
6.  It is hard for me to do chores around the house  0 1 2 3 4 
7.  I hurt or ache  0 1 2 3 4 
8.  I have low energy 0 1 2 3 4 
   
About My Feelings (PROBLEMS WITH…) 
Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.   I feel afraid or scared 0 1 2 3 4 
2.   I feel sad or blue 0 1 2 3 4 
3.   I feel angry 0 1 2 3 4 
4.   I have trouble sleeping 0 1 2 3 4 
5.   I worry about what will happen to me 0 1 2 3 4 
 
How I Get Along with Others (PROBLEMS WITH…) 
Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.  I have trouble getting along with other kids 0 1 2 3 4 
2.  Other kids do not want to be my friend  0 1 2 3 4 
3.  Other kids tease me  0 1 2 3 4 
4.  I cannot do things that other kids my age can do 0 1 2 3 4 
5.  It is hard to keep up when I play with other kids 0 1 2 3 4 
  
About School (PROBLEMS WITH…) 
Never Almost 
Never 
Some-
times 
Often Almost 
Always 
1.   It is hard to pay attention in class 0 1 2 3 4 
2.   I forget things 0 1 2 3 4 
3.   I have trouble keeping up with my schoolwork 0 1 2 3 4 
4.   I miss school because of not feeling well  0 1 2 3 4 
5.   I miss school to go to the doctor or hospital 0 1 2 3 4 
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Introduction: 
 Suite au progrès du traitement des tumeurs cérébrales pédiatriques, les enfants et les adolescents 
survivent plus longtemps suite à l'annonce de ce diagnostic (1). C'est pourquoi l'on s'intéresse de plus en 
plus au devenir à long terme de cette population. Plusieurs domaines tels que la cognition, les besoins 
médicaux, la performance académique et dans une moindre mesure, la performance motrice ont été 
explorés chez les enfants et adolescents survivants suite à une tumeur cérébrale (2, 3). Dans la pratique 
clinique en physiothérapie, nous observons que le maintien de l’équilibre en position debout représente 
un défi pour plusieurs de ces enfants et adolescents, sans pouvoir s’appuyer sur des données empiriques 
claires. Malgré un intérêt grandissant pour la question du devenir des survivants de tumeur cérébrale 
pédiatrique, l’évaluation de leur équilibre est souvent négligée.  
Les objectifs de nos travaux étaient de 1) examiner les écrits portant sur l’équilibre chez les 
survivants de tumeur cérébrale pédiatrique; 2) comparer l'équilibre debout et la qualité de vie entre les 
survivants et un groupe d’enfants témoins; et 3) examiner l'association entre l'équilibre debout et la 
qualité de vie chez les survivants. 
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Méthodologie: 
 Pour répondre au premier objectif, une analyse structurée des écrits a été complétée. Les mots 
clés: "neoplasm", "psychomotor control" et "postural balance", ont été combinés pour une recherche 
dans cinq bases de données différentes (Medline, CINAHL, PschyINFO, EMBASE et PEDro). Les titres 
et abrégés des articles ont été examinés pour leur pertinence selon des critères prédéterminés. Les 
articles inclus dans l'analyse ont été classés selon les critères du Oxford Centre for Evidence-Based 
Medicine Levels of Evidence (4).  
 Une étude transversale comparant l'équilibre debout et la qualité de vie entre un groupe de 
survivants de tumeur cérébrale pédiatrique de la fosse postérieure et un groupe d’enfants et adolescents 
sains a ensuite été réalisée avec l'approbation du Comité d'éthique de la recherche de l'Hôpital de 
Montréal pour Enfants du Centre Universitaire de Santé McGill. Participants: Un groupe expérimental  
de 6 enfants ou adolescents ayant survécu à une tumeur cérébrale ont été recrutés à la Clinique de neuro-
oncologie de l’Hôpital de Montréal pour Enfants.  Les participants, âgés de 5 à 18 ans, ayant complété 
avec succès, depuis au moins 6 mois, un traitement neurochirurgical, radio-oncologique ou de 
chimiothérapie pour une tumeur cérébrale de la fosse postérieure et ayant la capacité à se maintenir 
debout sans aide pendant une minute étaient éligible pour cette étude. Une groupe contrôle a été apparié 
selon l’âge et le genre aux enfants et adolescents survivants. Le consentement et l'assentiment des 
participants et de leurs parents ont été obtenus avant le début de l'étude. Collecte de données: Lors de 
l’évaluation, le poids et la taille des enfants même que leurs amplitudes articulaires, la force musculaire 
des membres inférieurs ainsi que la sensibilité des pieds furent mesurés. L'évaluation de l'équilibre fut 
effectuée à l’aide du Bruininks-Oseretsky Test of Motor Proficiency-2nd edition (BOT-2) et du Pediatric 
Balance Scale (PBS) (5, 6). Finalement, tous les enfants et leurs parents ont rempli le Pediatric Quality 
of Life Inventory (PedsQL4.0) (7). Analyses statistiques : Pour comparer les résultats de l’équilibre 
debout ainsi que la qualité de vie entre les deux groupes, mesurés à partir des outils cliniques, des tests 
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U de Mann-Whitney ont été complétés. L’association entre les différentes mesures d’équilibre et celles 
de la qualité de vie a été vérifiée avec des coefficients de corrélation de Spearman. 
 
Résultats: 
Notre recension des écrits a démontré que les survivants d'une tumeur cérébrale pédiatrique 
présentent des troubles de l’équilibre. Cependant, les limites méthodologiques des études nous 
empêchent de conclure de manière définitive sur l'impact de ces difficultés. Certaines limites des écrits 
disponibles sont: l'insuffisance de recherches axées dans le cadre clinique, l'absence d'évaluations de 
l'équilibre dynamique et finalement, le manque d'études visant à expliquer comment les troubles 
d'équilibre affectent la vie quotidienne des survivants. (Pour davantage des détails, veuillez consulter 
l'article publié dans le European Journal of Cancer Care (8)). 
Le projet de recherche clinique a démontré plusieurs résultats intéressants. Six survivants de 
tumeurs cérébrales de la fosse postérieure (tous des garçons et diagnostiqués entre 4 et 11 ans) ont été 
recrutés pour participer dans cette étude. En ce qui concerne la performance lors des mesures cliniques 
de l'équilibre, les scores au PBS étaient similaires pour les deux groupes et ont démontré un effet 
plafond important. Par contre, la sous-échelle d'équilibre du BOT-2 a révélé une différence significative 
dans les capacités d'équilibre debout entre les deux groupes (p=0.004). Les survivants présentaient des 
capacités d'équilibre sous la moyenne comparativement au groupe de contrôle qui se retrouve dans la 
moyenne selon les normes proposées par ce test. 
La qualité de vie, mesurée par le PedsQL4.0, se situait parmi les valeurs normatives pour les 
deux groupes d'enfants et adolescents (7).  De plus, les participants et leurs parents ont coté la qualité de 
vie de manière similaire. Pour explorer l'association entre les capacités d'équilibre et la qualité de vie, le 
BOT-2 a été utilisé car le PBS a démontré un effet plafond. Une bonne association (ρ= 0.715) a été 
quantifiée entre les scores dans le domaine physique du PedsQL4.0 et le BOT-2. 
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Retombées cliniques: 
 Les résultats de cette étude démontrent que les enfants et adolescents ayant survécu à une 
tumeur cérébrale de la fosse postérieure présentent des troubles d'équilibre persistants. Cela suggère 
qu'un suivi à long terme en physiothérapie de cette population pourrait être nécessaire. Il pourrait par 
exemple être recommandé que tous les survivants de tumeurs cérébrales pédiatriques subissent un 
dépistage de leurs habilites équilibre une fois leur traitement complété. Selon les résultats de la présente 
étude, la sous-échelle d'équilibre de BOT-2 pourrait être un outil sensible à utiliser. Même si les qualités 
psychométriques n'ont pas été étudiées avec cette population, le BOT-2 est un outil facile à administrer 
avec des valeurs normatives. Si ce dépistage révèle des difficultés au niveau de l'équilibre pour un 
patient, une évaluation clinique ou en laboratoire plus complète et un plan d'intervention individualisé 
seraient indiqués. 
 Bien que les enfants et adolescents ayant survécu à une tumeur cérébrale de la fosse postérieure 
rapportent une qualité de vie comparable aux normes, les résultats de la présente étude suggèrent que de 
meilleures capacités d'équilibre debout pourraient être reliées à de plus hauts scores du domaine 
physique de la PedsQL4.0. Ceci suggère que l'amélioration de l'équilibre debout des survivants serait 
bénéfique à leur qualité de vie. Il serait probablement utile de développer des programmes locaux et 
interdisciplinaires qui visent à suivre tous les survivants de tumeurs cérébrales pédiatriques afin de 
répondre à leurs besoins en réadaptation à plus long terme. 
 
Limites: 
 La limite la plus évidente de cette étude est le petit nombre de sujets recrutés. Plusieurs facteurs 
entrent en ligne de compte, mais de toute façon, des résultats significatifs ont été retrouvés. D'autres 
limites sont que l'évaluateur n'était pas aveugle à quel groupe appartenaient les participants et l'ébauche 
de cette 'étude transversale ne permettait pas d'étudier l'évolution des capacités d'équilibre des survivants 
dans le temps. 
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Conclusions: 
 Avec les améliorations dans la survie des enfants et adolescents diagnostiqués avec une tumeur 
cérébrale, le devenir à long terme de cette population est un domaine émergent dans la recherche en 
réadaptation. Il existe peu d'écrits dans le domaine de la physiothérapie pour ces survivants. La présente 
étude confirme que les survivants des tumeurs cérébrales de la fosse postérieure possèdent des troubles 
d'équilibre après que leurs traitements soient terminés. Malgré cela, leur qualité de vie demeure normale 
lorsque comparée aux normes et les capacités d'équilibre sembles reliés à ces scores. Dans le futur, il 
serait essentiel d'entreprendre des études longitudinales et multicentriques pour avoir un portrait plus 
complet des effets secondaires des traitements médicaux pour les enfants et adolescents ayant survécu à 
une tumeur cérébrale. L'ajout des mesure obtenues à l'aide d'une plateforme de force dans un contexte 
clinique (ex: Balance Master, Biodex, console WiiFit, etc.) mériterait également d'être considéré. 
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STANDING BALANCE AND QUALITY OF LIFE IN SURVIVORS OF CHILDHOOD 
POSTERIOR FOSSA BRAIN TUMOURS: AN EXPLORATORY STUDY
Melissa Turner, B.Sc.PT1,2, Dany Gagnon, PT PhD1,3 & Isabelle Gagnon, PT PhD2,4
1. École de Réadaptation, Faculté de Medecine, Université de Montréal, 2. Physiotherapy Department, Montreal Children’s Hospital, McGill 
University Health Centre, 3. Centre de recherche interdisciplinaire en réadaptation du Grand Montréal, 4. School of Physical and 
Occupational Therapy, Faculty of Medicine, McGill University
•The most frequent location of childhood brain tumours is the 
posterior fossa, a region that includes the cerebellum1
•Few studies assess standing balance in a clinically-oriented way 
in this population2
•The available literature demonstrates poorer balance abilities in 
this group2
•Standing balance difficulties may interfere with motor 
functions, in turn affecting health-related quality of life (HRQOL) 
•PARTICIPANTS: 6 survivors of pediatric posterior fossa brain 
tumours (all male, aged 7-18 years old) were recruited and 6  
age- and gender-matched controls
•OUTCOME MEASURES:
•Balance: balance subtest of the Bruininks-Oseretsky Test 
of Motor Proficiency (BOT-2) and the Pediatric Balance 
Scale (PBS)
•HRQOL: Pediatric Quality of Life Inventory Generic Core 
Scales (PedsQL4.0)
•STATISTICAL ANALYSIS: Mann Whitney U tests to compare 
results between groups and Spearman’s rank correlation 
coefficient to determine association between balance abilities 
and HRQOL
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•To compare standing balance and health-related quality of life 
(HRQOL) between survivors of pediatric posterior fossa brain 
tumours and healthy controls
•To explore any associations between balance abilities and 
HRQOL
•PBS demonstrates a ceiling effect
•BOT-2 balance subtest scores significantly lower in 
survivors 
•Based on normative values of the BOT-2:
•The experimental groups’ balance abilities fall 
into the below average range
•The control groups’ balance abilities are in the 
average category
•HRQOL similar in both groups (self-report scores)
•HRQOL scores fall into the normative range for all 
participants in all domains
•No significant differences found likely owing to the 
small sample size
•Survivors of posterior fossa brain tumours demonstrate 
significant balance deficits after ending treatment but 
report relatively normal HRQOL
•Better balance abilities may contribute to higher 
HRQOL in this group
•The balance subtest of the BOT-2 may be the most 
appropriate tool to use to screen for balance difficulties 
in this population
•This research study may be a step towards recognizing 
the persistent physical difficulties faced by survivors 
and likely supports the needs for continued 
physiotherapy follow-up in this population
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**p=0.004
•Scores on BOT-2 were used as PBS demonstrated a 
ceiling effect
•Correlated with the physical domain summary score 
of the PedsQL4.0
 
